{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:22:37Z","timestamp":1793388157565,"version":"4.5.0"},"reference-count":364,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dementia with Lewy bodies (DLB) is epitomized by the pathognomonic manifestation of \u03b1-synuclein-laden Lewy bodies within selectively vulnerable neurons in the brain. By virtue of prion-like inheritance, the \u03b1-synuclein protein inexorably undergoes extensive conformational metamorphoses and culminate in the form of fibrillar polymorphs, instigating calamitous damage to the brain\u2019s neuropsychological networks. This epiphenomenon is nebulous, however, by lingering uncertainty over the quasi \u201cpathogenic\u201d behavior of \u03b1-synuclein conformers in DLB pathobiology. Despite numerous attempts, a monolithic \u201c\u03b1-synuclein\u201d paradigm that is able to untangle the enigma enshrouding the clinicopathological spectrum of DLB has failed to emanate. In this article, we review conceptual frameworks of \u03b1-synuclein dependent cell-autonomous and non-autonomous mechanisms that are likely to facilitate the transneuronal spread of degeneration through the neuraxis. In particular, we describe how the progressive demise of susceptible neurons may evolve from cellular derangements perpetrated by \u03b1-synuclein misfolding and aggregation. Where pertinent, we show how these bona fide mechanisms may mutually accentuate \u03b1-synuclein-mediated neurodegeneration in the DLB brain.<\/jats:p>","DOI":"10.1186\/s13578-021-00709-y","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T13:03:11Z","timestamp":1637326991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["\u03b1-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox"],"prefix":"10.1186","volume":"11","author":[{"given":"Christopher","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka James","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-1243","authenticated-orcid":false,"given":"Ishwar","family":"Parhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"issue":"1","key":"709_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat Rev Neurol. 2013;9(1):13. https:\/\/doi.org\/10.1038\/nrneurol.2012.242.","journal-title":"Nat Rev Neurol"},{"key":"709_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-4-431-55948-1_1","volume-title":"Dementia with Lewy bodies","author":"K Kosaka","year":"2017","unstructured":"Kosaka K. History and latest concepts of Lewy body disease and dementia with Lewy bodies. In: Dementia with Lewy bodies. Tokyo: Springer; 2017. p. 3\u20139. https:\/\/doi.org\/10.1007\/978-4-431-55948-1_1."},{"issue":"4","key":"709_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/2F089198870201500402","volume":"15","author":"JL Heidebrink","year":"2002","unstructured":"Heidebrink JL. Is dementia with Lewy bodies the second most common cause of dementia? J Geriatr Psychiatry Neurol. 2002;15(4):182\u20137. https:\/\/doi.org\/10.1177\/2F089198870201500402.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"709_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","volume":"10","author":"JP Kane","year":"2018","unstructured":"Kane JP, Surendranathan A, Bentley A, Barker SA, Taylor J-P, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG. Clinical prevalence of Lewy body dementia. Alzheimer\u2019s Res Ther. 2018;10(1):19. https:\/\/doi.org\/10.1186\/s13195-018-0350-6.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"5","key":"709_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s1474-4422(17)30074-1","volume":"16","author":"C Mueller","year":"2017","unstructured":"Mueller C, Ballard C, Corbett A, Aarsland D. The prognosis of dementia with Lewy bodies. Lancet Neurol. 2017;16(5):390\u20138. https:\/\/doi.org\/10.1016\/s1474-4422(17)30074-1.","journal-title":"Lancet Neurol"},{"issue":"5","key":"709_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/wnl.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry E, Dickson DW, Hansen L, Salmon D, Lowe J, Mirra S, Byrne E. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113\u201324. https:\/\/doi.org\/10.1212\/wnl.47.5.1113.","journal-title":"Neurology"},{"issue":"2","key":"709_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s1474-4422(19)30153-x","volume":"19","author":"J-P Taylor","year":"2020","unstructured":"Taylor J-P, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ, T O\u2019Brien J. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19(2):157\u201369. https:\/\/doi.org\/10.1016\/s1474-4422(19)30153-x.","journal-title":"Lancet Neurol"},{"issue":"11","key":"709_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/gps.930091107","volume":"9","author":"S Shergill","year":"1994","unstructured":"Shergill S, Mullan E, D\u2019ath P, Katona C. What is the clinical prevalence of Lewy body dementia? Int J Geriatr Psychiatry. 1994;9(11):907\u201312. https:\/\/doi.org\/10.1002\/gps.930091107.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1\u20132","key":"709_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0022-510X(90)90037-N","volume":"100","author":"RH Perry","year":"1990","unstructured":"Perry RH, Irving D, Tomlinson BE. Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. J Neurol Sci. 1990;100(1\u20132):223\u201333. https:\/\/doi.org\/10.1016\/0022-510X(90)90037-N.","journal-title":"J Neurol Sci"},{"issue":"2","key":"709_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci. 2002;14(2):223\u201336. https:\/\/doi.org\/10.1176\/jnp.14.2.223.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"9","key":"709_CR11","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"J Obeso","year":"2017","unstructured":"Obeso J, Stamelou M, Goetz C, Poewe W, Lang A, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S. Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy. Mov Disord. 2017;32(9):1264\u2013310. https:\/\/doi.org\/10.1002\/mds.27115.","journal-title":"Mov Disord"},{"issue":"1","key":"709_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1076\/jhin.11.1.19.9106","volume":"11","author":"B Holdorff","year":"2002","unstructured":"Holdorff B. Friedrich Heinrich Lewy (1885\u20131950) and his work. J Hist Neurosci. 2002;11(1):19\u201328. https:\/\/doi.org\/10.1076\/jhin.11.1.19.9106.","journal-title":"J Hist Neurosci"},{"issue":"12","key":"709_CR13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/mds.22956","volume":"25","author":"AM Rodrigues e Silva","year":"2010","unstructured":"Rodrigues e Silva AM, Geldsetzer F, Holdorff B, Kielhorn FW, Balzer-Geldsetzer M, Oertel WH, Hurtig H, Dodel R. Who was the man who discovered the \u201cLewy bodies\u201d? Mov Disord. 2010;25(12):1765\u201373. https:\/\/doi.org\/10.1002\/mds.22956.","journal-title":"Mov Disord"},{"issue":"6","key":"709_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/mds.21855","volume":"23","author":"AJ Lees","year":"2008","unstructured":"Lees AJ, Selikhova M, Andrade LA, Duyckaerts C. The black stuff and konstantin nikolaevich tretiakoff. Mov Disord. 2008;23(6):777\u201383. https:\/\/doi.org\/10.1002\/mds.21855.","journal-title":"Mov Disord"},{"issue":"2","key":"709_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/bf00690978","volume":"42","author":"K Kosaka","year":"1978","unstructured":"Kosaka K. Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol. 1978;42(2):127\u201334. https:\/\/doi.org\/10.1007\/bf00690978.","journal-title":"Acta Neuropathol"},{"key":"709_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1440-1789.2000.00301.x","volume":"20","author":"K Kosaka","year":"2000","unstructured":"Kosaka K. Diffuse Lewy body disease. Neuropathology. 2000;20:73\u20138. https:\/\/doi.org\/10.1046\/j.1440-1789.2000.00301.x.","journal-title":"Neuropathology"},{"issue":"5","key":"709_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/brain\/110.5.1131","volume":"110","author":"W Gibb","year":"1987","unstructured":"Gibb W, Esiri M, Lees A. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain. 1987;110(5):1131\u201353. https:\/\/doi.org\/10.1093\/brain\/110.5.1131.","journal-title":"Brain"},{"issue":"6","key":"709_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"W Gibb","year":"1988","unstructured":"Gibb W, Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745\u201352. https:\/\/doi.org\/10.1136\/jnnp.51.6.745.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"709_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1017\/s0033291700038484","volume":"22","author":"IG McKeith","year":"1992","unstructured":"McKeith IG, Perry R, Fairbairn A, Jabeen S, Perry E. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med. 1992;22(4):911\u201322. https:\/\/doi.org\/10.1017\/s0033291700038484.","journal-title":"Psychol Med"},{"issue":"1","key":"709_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/wnl.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100. https:\/\/doi.org\/10.1212\/wnl.0000000000004058.","journal-title":"Neurology"},{"issue":"5","key":"709_CR21","first-page":"185","volume":"3","author":"K Kosaka","year":"1984","unstructured":"Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree\u2014a new disease? Clin Neuropathol. 1984;3(5):185.","journal-title":"Clin Neuropathol"},{"issue":"11","key":"709_CR22","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci. 1998;95(11):6469\u201373. https:\/\/doi.org\/10.1073\/pnas.95.11.6469.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"709_CR23","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu P-H, Tomita T, Nakaya K, Lee V, Trojanowski JQ, Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol. 1998;152(4):879.","journal-title":"Am J Pathol"},{"issue":"10","key":"709_CR24","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/wnl.54.10.1916","volume":"54","author":"H Hurtig","year":"2000","unstructured":"Hurtig H, Trojanowski J, Galvin J, Ewbank D, Schmidt M, Lee V-Y, Clark C, Glosser G, Stern M, Gollomp S. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology. 2000;54(10):1916\u201321. https:\/\/doi.org\/10.1212\/wnl.54.10.1916.","journal-title":"Neurology"},{"issue":"2","key":"709_CR25","first-page":"367","volume":"152","author":"A Takeda","year":"1998","unstructured":"Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Abnormal accumulation of NACP\/alpha-synuclein in neurodegenerative disorders. Am J Pathol. 1998;152(2):367.","journal-title":"Am J Pathol"},{"issue":"1","key":"709_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00441-017-2733-6","volume":"373","author":"MG Cersosimo","year":"2018","unstructured":"Cersosimo MG. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies. Cell Tissue Res. 2018;373(1):233\u201343. https:\/\/doi.org\/10.1007\/s00441-017-2733-6.","journal-title":"Cell Tissue Res"},{"issue":"3","key":"709_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"P Mattila","year":"2000","unstructured":"Mattila P, Rinne J, Helenius H, Dickson DW, R\u00f6ytt\u00e4 M. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol. 2000;100(3):285\u201390. https:\/\/doi.org\/10.1007\/s004019900168.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"709_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/jnnp-2016-314857","volume":"88","author":"C-H Lin","year":"2017","unstructured":"Lin C-H, Yang S-Y, Horng H-E, Yang C-C, Chieh J-J, Chen H-H, Liu B-H, Chiu M-J. Plasma \u03b1-synuclein predicts cognitive decline in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2017;88(10):818\u201324. https:\/\/doi.org\/10.1136\/jnnp-2016-314857.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"709_CR29","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1073\/pnas.060009897","volume":"97","author":"S Buldyrev","year":"2000","unstructured":"Buldyrev S, Cruz L, Gomez-Isla T, Gomez-Tortosa E, Havlin S, Le R, Stanley H, Urbanc B, Hyman B. Description of microcolumnar ensembles in association cortex and their disruption in Alzheimer and Lewy body dementias. Proc Natl Acad Sci. 2000;97(10):5039\u201343. https:\/\/doi.org\/10.1073\/pnas.060009897.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"709_CR30","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","volume":"74","author":"C Colosimo","year":"2003","unstructured":"Colosimo C, Hughes A, Kilford L, Lees A. Lewy body cortical involvement may not always predict dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2003;74(7):852\u20136. https:\/\/doi.org\/10.1136\/jnnp.74.7.852.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"709_CR31","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/wnl.53.9.2003","volume":"53","author":"T Gomez-Isla","year":"1999","unstructured":"Gomez-Isla T, Growdon W, McNamara M, Newell K, Gomez-Tortosa E, Hedley-Whyte E, Hyman B. Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology. 1999;53(9):2003\u20132003. https:\/\/doi.org\/10.1212\/wnl.53.9.2003.","journal-title":"Neurology"},{"issue":"1","key":"709_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0303-8467(94)00060-J","volume":"97","author":"RA de Vos","year":"1995","unstructured":"de Vos RA, Jansen EN, Stam FC, Ravid R, Swaab DF. \u2018Lewy body disease\u2019: clinico-pathological correlations in 18 consecutive cases of Parkinson\u2019s disease with and without dementia. Clin Neurol Neurosurg. 1995;97(1):13\u201322. https:\/\/doi.org\/10.1016\/0303-8467(94)00060-J.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"709_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","volume":"106","author":"E K\u00f6vari","year":"2003","unstructured":"K\u00f6vari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson\u2019s disease. Acta Neuropathol. 2003;106(1):83\u20138. https:\/\/doi.org\/10.1007\/s00401-003-0705-2.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"709_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00005072-199705000-00006","volume":"56","author":"W Samuel","year":"1997","unstructured":"Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol. 1997;56(5):499\u2013508. https:\/\/doi.org\/10.1097\/00005072-199705000-00006.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"709_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1750-3639.2004.tb00082.x","volume":"14","author":"E Dalfo","year":"2004","unstructured":"Dalfo E, Albasanz J, Martin M, Ferrer I. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular \u03b1-synuclein\/phospholipase C (PLC\u03b21) interactions. Brain Pathol. 2004;14(4):388\u201398. https:\/\/doi.org\/10.1111\/j.1750-3639.2004.tb00082.x.","journal-title":"Brain Pathol"},{"key":"709_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-7091-6846-2_8","volume-title":"Dementia in Parkinsonism","author":"R Perry","year":"1997","unstructured":"Perry R, McKeith I, Perry E. Lewy body dementia\u2014clinical, pathological and neurochemical interconnections. In: Dementia in Parkinsonism. New York: Springer; 1997. p. 95\u2013109. https:\/\/doi.org\/10.1007\/978-3-7091-6846-2_8."},{"issue":"12","key":"709_CR37","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/archneur.56.12.1458","volume":"56","author":"MN Sabbagh","year":"1999","unstructured":"Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thomas R, Masliah E, Thal LJ. Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease. Arch Neurol. 1999;56(12):1458\u201361. https:\/\/doi.org\/10.1001\/archneur.56.12.1458.","journal-title":"Arch Neurol"},{"issue":"11","key":"709_CR38","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1523\/jneurosci.5427-08.2009","volume":"29","author":"CY Chung","year":"2009","unstructured":"Chung CY, Koprich JB, Siddiqi H, Isacson O. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV \u03b1-synucleinopathy. J Neurosci. 2009;29(11):3365\u201373. https:\/\/doi.org\/10.1523\/jneurosci.5427-08.2009.","journal-title":"J Neurosci"},{"key":"709_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2016.04.005","volume":"28","author":"CM Henstridge","year":"2016","unstructured":"Henstridge CM, Pickett E, Spires-Jones TL. Synaptic pathology: a shared mechanism in neurological disease. Ageing Res Rev. 2016;28:72\u201384. https:\/\/doi.org\/10.1016\/j.arr.2016.04.005.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"709_CR40","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1523\/jneurosci.4564-06.2007","volume":"27","author":"ML Kramer","year":"2007","unstructured":"Kramer ML, Schulz-Schaeffer WJ. Presynaptic \u03b1-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci. 2007;27(6):1405\u201310. https:\/\/doi.org\/10.1523\/jneurosci.4564-06.2007.","journal-title":"J Neurosci"},{"issue":"2","key":"709_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0022-510x(02)00006-0","volume":"195","author":"W Marui","year":"2002","unstructured":"Marui W, Iseki E, Nakai T, Miura S, Kato M, U\u00e9da K, Kosaka K. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci. 2002;195(2):153\u20139. https:\/\/doi.org\/10.1016\/s0022-510x(02)00006-0.","journal-title":"J Neurol Sci"},{"issue":"2","key":"709_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.26479","volume":"31","author":"L Calo","year":"2016","unstructured":"Calo L, Wegrzynowicz M, Santiva\u00f1ez-Perez J, Grazia Spillantini M. Synaptic failure and \u03b1-synuclein. Mov Disord. 2016;31(2):169\u201377. https:\/\/doi.org\/10.1002\/mds.26479.","journal-title":"Mov Disord"},{"issue":"12","key":"709_CR43","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.neurobiolaging.2014.06.015","volume":"35","author":"DR Whitfield","year":"2014","unstructured":"Whitfield DR, Vallortigara J, Alghamdi A, Howlett D, Hortob\u00e1gyi T, Johnson M, Attems J, Newhouse S, Ballard C, Thomas AJ. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer\u2019s disease: association with cognitive impairment. Neurobiol Aging. 2014;35(12):2836\u201344. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.06.015.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"709_CR44","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","volume":"12","author":"E Bereczki","year":"2016","unstructured":"Bereczki E, Francis PT, Howlett D, Pereira JB, H\u00f6glund K, Bogstedt A, Cedazo-Minguez A, Baek J-H, Hortob\u00e1gyi T, Attems J. Synaptic proteins predict cognitive decline in Alzheimer\u2019s disease and Lewy body dementia. Alzheimers Dement. 2016;12(11):1149\u201358. https:\/\/doi.org\/10.1016\/j.jalz.2016.04.005.","journal-title":"Alzheimers Dement"},{"key":"709_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuroscience.2011.10.042","volume":"200","author":"G Muntan\u00e9","year":"2012","unstructured":"Muntan\u00e9 G, Ferrer I, Martinez-Vicente M. \u03b1-Synuclein phosphorylation and truncation are normal events in the adult human brain. Neuroscience. 2012;200:106\u201319. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.10.042.","journal-title":"Neuroscience"},{"key":"709_CR46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue L-F, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG. Changes in properties of serine 129 phosphorylated \u03b1-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol. 2013;240:190\u2013204. https:\/\/doi.org\/10.1016\/j.expneurol.2012.11.020.","journal-title":"Exp Neurol"},{"issue":"12","key":"709_CR47","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/brain\/awx275","volume":"140","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Mu\u00f1oz L, Querol-Vilaseca M, Mart\u00edn-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O. Synaptic phosphorylated \u03b1-synuclein in dementia with Lewy bodies. Brain. 2017;140(12):3204\u201314. https:\/\/doi.org\/10.1093\/brain\/awx275.","journal-title":"Brain"},{"issue":"3","key":"709_CR48","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1006\/nbdi.2000.0286","volume":"7","author":"BC Campbell","year":"2000","unstructured":"Campbell BC, Li Q-X, Culvenor JG, J\u00e4k\u00e4l\u00e4 P, Cappai R, Beyreuther K, Masters CL, McLean CA. Accumulation of insoluble \u03b1-synuclein in dementia with Lewy bodies. Neurobiol Dis. 2000;7(3):192\u2013200. https:\/\/doi.org\/10.1006\/nbdi.2000.0286.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"709_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00401-005-0027-7","volume":"111","author":"J Klucken","year":"2006","unstructured":"Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte E, Frosch MP, Growdon JH, McLean PJ, Hyman BT. Clinical and biochemical correlates of insoluble \u03b1-synuclein in dementia with Lewy bodies. Acta Neuropathol. 2006;111(2):101\u20138. https:\/\/doi.org\/10.1007\/s00401-005-0027-7.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"709_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00401-010-0676-z","volume":"120","author":"K Tanji","year":"2010","unstructured":"Tanji K, Mori F, Mimura J, Itoh K, Kakita A, Takahashi H, Wakabayashi K. Proteinase K-resistant \u03b1-synuclein is deposited in presynapses in human Lewy body disease and A53T \u03b1-synuclein transgenic mice. Acta Neuropathol. 2010;120(2):145\u201354. https:\/\/doi.org\/10.1007\/s00401-010-0676-z.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"709_CR51","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1023\/a:1026061021946","volume":"28","author":"J Klucken","year":"2003","unstructured":"Klucken J, McLean PJ, Gomez-Tortosa E, Ingelsson M, Hyman BT. Neuritic alterations and neural system dysfunction in Alzheimer\u2019s disease and dementia with Lewy bodies. Neurochem Res. 2003;28(11):1683\u201391. https:\/\/doi.org\/10.1023\/a:1026061021946.","journal-title":"Neurochem Res"},{"issue":"1","key":"709_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1533317507310565","volume":"23","author":"GJ Revuelta","year":"2008","unstructured":"Revuelta GJ, Rosso A, Lippa CF. Neuritic pathology as a correlate of synaptic loss in dementia with Lewy bodies. Am J Alzheimer\u2019s Dis Other Dement. 2008;23(1):97\u2013102. https:\/\/doi.org\/10.1177\/1533317507310565.","journal-title":"Am J Alzheimer\u2019s Dis Other Dement"},{"issue":"12","key":"709_CR53","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/s0962-8924(00)01852-3","volume":"10","author":"RR Kopito","year":"2000","unstructured":"Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000;10(12):524\u201330. https:\/\/doi.org\/10.1016\/s0962-8924(00)01852-3.","journal-title":"Trends Cell Biol"},{"issue":"11","key":"709_CR54","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1046\/j.1460-9568.2002.02301.x","volume":"16","author":"KSP McNaught","year":"2002","unstructured":"McNaught KSP, Shashidharan P, Perl DP, Jenner P, Olanow CW. Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci. 2002;16(11):2136\u201348. https:\/\/doi.org\/10.1046\/j.1460-9568.2002.02301.x.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"709_CR55","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4(2):160\u20134. https:\/\/doi.org\/10.1038\/ncb748.","journal-title":"Nat Cell Biol"},{"issue":"40","key":"709_CR56","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.m600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, De Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M. Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006;281(40):29739\u201352. https:\/\/doi.org\/10.1074\/jbc.m600933200.","journal-title":"J Biol Chem"},{"issue":"50","key":"709_CR57","doi-asserted-by":"publisher","first-page":"49071","DOI":"10.1074\/jbc.m208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM-Y, Trojanowski JQ, Mann D, Iwatsubo T. Phosphorylated \u03b1-synuclein is ubiquitinated in \u03b1-synucleinopathy lesions. J Biol Chem. 2002;277(50):49071\u20136. https:\/\/doi.org\/10.1074\/jbc.m208046200.","journal-title":"J Biol Chem"},{"issue":"3","key":"709_CR58","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s0014-5793(98)01146-6","volume":"436","author":"RA Crowther","year":"1998","unstructured":"Crowther RA, Jakes R, Spillantini MG, Goedert M. Synthetic filaments assembled from C-terminally truncated \u03b1-synuclein. FEBS Lett. 1998;436(3):309\u201312. https:\/\/doi.org\/10.1016\/s0014-5793(98)01146-6.","journal-title":"FEBS Lett"},{"issue":"5493","key":"709_CR59","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"BI Giasson","year":"2000","unstructured":"Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM-Y. Oxidative damage linked to neurodegeneration by selective \u03b1-synuclein nitration in synucleinopathy lesions. Science. 2000;290(5493):985\u20139. https:\/\/doi.org\/10.1126\/science.290.5493.985.","journal-title":"Science"},{"issue":"5","key":"709_CR60","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/s0002-9440(10)64781-5","volume":"157","author":"JE Duda","year":"2000","unstructured":"Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VMY, Trojanowski JQ. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol. 2000;157(5):1439\u201345. https:\/\/doi.org\/10.1016\/s0002-9440(10)64781-5.","journal-title":"Am J Pathol"},{"issue":"9","key":"709_CR61","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"A-L Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier A-L, Burtscher J, Maharjan N, Weerens L, Croisier M, Kuttler F, Leleu M, Knott GW, Lashuel HA. The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci. 2020;117(9):4971\u201382. https:\/\/doi.org\/10.1073\/pnas.1913904117.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"709_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-014-0164-0","volume":"2","author":"JS Miners","year":"2014","unstructured":"Miners JS, Renfrew R, Swirski M, Love S. Accumulation of \u03b1-synuclein in dementia with Lewy bodies is associated with decline in the \u03b1-synuclein-degrading enzymes kallikrein-6 and calpain-1. Acta Neuropathol Commun. 2014;2(1):1\u201311. https:\/\/doi.org\/10.1186\/s40478-014-0164-0.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"709_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/archneur.65.4.514","volume":"65","author":"T Ikeuchi","year":"2008","unstructured":"Ikeuchi T, Kakita A, Shiga A, Kasuga K, Kaneko H, Tan C-F, Idezuka J, Wakabayashi K, Onodera O, Iwatsubo T. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch Neurol. 2008;65(4):514\u20139. https:\/\/doi.org\/10.1001\/archneur.65.4.514.","journal-title":"Arch Neurol"},{"issue":"2","key":"709_CR64","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atar\u00e9s B. The new mutation, E46K, of \u03b1-synuclein causes parkinson and Lewy body dementia. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc. 2004;55(2):164\u201373. https:\/\/doi.org\/10.1002\/ana.10795.","journal-title":"Ann Neurol Off J Am Neurol Assoc Child Neurol Soc"},{"issue":"23","key":"709_CR65","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","volume":"23","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet. 2014;23(23):6139\u201346. https:\/\/doi.org\/10.1093\/hmg\/ddu334.","journal-title":"Hum Mol Genet"},{"issue":"5646","key":"709_CR66","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"A Singleton","year":"2003","unstructured":"Singleton A, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra AN, Lincoln S. [alpha]-synuclein locus triplication causes Parkinson\u2019s disease. Science. 2003;302(5646):841\u20132. https:\/\/doi.org\/10.1126\/science.1090278.","journal-title":"Science"},{"issue":"7","key":"709_CR67","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci. 2001;2(7):492\u2013501. https:\/\/doi.org\/10.1038\/35081564.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"709_CR68","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/jpet.109.158436","volume":"332","author":"P Putcha","year":"2010","unstructured":"Putcha P, Danzer KM, Kranich LR, Scott A, Silinski M, Mabbett S, Hicks CD, Veal JM, Steed PM, Hyman BT. Brain-permeable small-molecule inhibitors of Hsp90 prevent \u03b1-synuclein oligomer formation and rescue \u03b1-synuclein-induced toxicity. J Pharmacol Exp Ther. 2010;332(3):849\u201357. https:\/\/doi.org\/10.1124\/jpet.109.158436.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"709_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa010","volume":"2","author":"JB Sanderson","year":"2020","unstructured":"Sanderson JB, De S, Jiang H, Rovere M, Jin M, Zaccagnini L, Hays Watson A, De Boni L, Lagomarsino VN, Young-Pearse TL. Analysis of \u03b1-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies. Brain Commun. 2020;2(1): fcaa010. https:\/\/doi.org\/10.1093\/braincomms\/fcaa010.","journal-title":"Brain Commun"},{"issue":"1","key":"709_CR70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1212\/wnl.48.1.126","volume":"48","author":"LA Hansen","year":"1997","unstructured":"Hansen LA, Samuel W. Criteria for Alzheimer\u2019s disease and the nosology of dementia with Lewy bodies. Neurology. 1997;48(1):126\u201332. https:\/\/doi.org\/10.1212\/wnl.48.1.126.","journal-title":"Neurology"},{"issue":"1","key":"709_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med. 2018;16(1):1\u201316. https:\/\/doi.org\/10.1186\/s12916-018-1016-8.","journal-title":"BMC Med"},{"key":"709_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28288","author":"G Levy","year":"2020","unstructured":"Levy G, Levin B, Engelhardt E. The nosology of Lewy body disorders from analytic-epidemiologic and statistical vantage points. Mov Disord. 2020. https:\/\/doi.org\/10.1002\/mds.28288.","journal-title":"Mov Disord"},{"issue":"s3","key":"709_CR73","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/jad-2006-9s347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimer\u2019s Dis. 2006;9(s3):417\u201323. https:\/\/doi.org\/10.3233\/jad-2006-9s347.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"4","key":"709_CR74","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/gps.1094","volume":"19","author":"F Cormack","year":"2004","unstructured":"Cormack F, Aarsland D, Ballard C, Tov\u00e9e MJ. Pentagon drawing and neuropsychological performance in Dementia with Lewy bodies, Alzheimer\u2019s disease, Parkinson\u2019s disease and Parkinson\u2019s disease with dementia. Int J Geriatr Psychiatry. 2004;19(4):371\u20137. https:\/\/doi.org\/10.1002\/gps.1094.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"8","key":"709_CR75","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1212\/wnl.54.8.1616","volume":"54","author":"M Walker","year":"2000","unstructured":"Walker M, Ayre G, Cummings J, Wesnes K, McKeith I, O\u2019brien J, Ballard C. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer\u2019s disease, and vascular dementia. Neurology. 2000;54(8):1616\u201325. https:\/\/doi.org\/10.1212\/wnl.54.8.1616.","journal-title":"Neurology"},{"issue":"4","key":"709_CR76","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/13854040500376831","volume":"20","author":"TJ Ferman","year":"2006","unstructured":"Ferman TJ, Smith GE, Boeve BF, Graff-Radford NR, Lucas JA, Knopman DS, Petersen RC, Ivnik RJ, Wszolek Z, Uitti R. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer\u2019s disease. Clin Neuropsychol. 2006;20(4):623\u201336. https:\/\/doi.org\/10.1080\/13854040500376831.","journal-title":"Clin Neuropsychol"},{"issue":"4","key":"709_CR77","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/brain\/awh088","volume":"127","author":"EJ Burton","year":"2004","unstructured":"Burton EJ, McKeith IG, Burn DJ, Williams ED, O\u2019Brien JT. Cerebral atrophy in Parkinson\u2019s disease with and without dementia: a comparison with Alzheimer\u2019s disease, dementia with Lewy bodies and controls. Brain. 2004;127(4):791\u2013800. https:\/\/doi.org\/10.1093\/brain\/awh088.","journal-title":"Brain"},{"issue":"3","key":"709_CR78","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ana.1133","volume":"50","author":"S Minoshima","year":"2001","unstructured":"Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer\u2019s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc. 2001;50(3):358\u201365. https:\/\/doi.org\/10.1002\/ana.1133.","journal-title":"Ann Neurol Off J Am Neurol Assoc Child Neurol Soc"},{"issue":"1","key":"709_CR79","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/mds.10633","volume":"19","author":"E Noe","year":"2004","unstructured":"Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer\u2019s disease and Parkinson\u2019s disease with dementia. Mov Disord. 2004;19(1):60\u20137. https:\/\/doi.org\/10.1002\/mds.10633.","journal-title":"Mov Disord"},{"issue":"1","key":"709_CR80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/jnnp.67.1.66","volume":"67","author":"R Barber","year":"1999","unstructured":"Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O\u2019brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer\u2019s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry. 1999;67(1):66\u201372. https:\/\/doi.org\/10.1136\/jnnp.67.1.66.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"709_CR81","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","volume":"67","author":"C Ballard","year":"2006","unstructured":"Ballard C, Ziabreva I, Perry R, Larsen J, O\u2019brien J, McKeith I, Perry E, Aarsland D. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology. 2006;67(11):1931\u20134. https:\/\/doi.org\/10.1212\/01.wnl.0000249130.63615.cc.","journal-title":"Neurology"},{"issue":"4","key":"709_CR82","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3233\/jad-170274","volume":"59","author":"R Skogseth","year":"2017","unstructured":"Skogseth R, Hortob\u00e1gyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D. Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology. J Alzheimers Dis. 2017;59(4):1139\u201352. https:\/\/doi.org\/10.3233\/jad-170274.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"709_CR83","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","volume":"150","author":"L Walker","year":"2019","unstructured":"Walker L, Stefanis L, Attems J. Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies\u2014current issues and future directions. J Neurochem. 2019;150(5):467\u201374. https:\/\/doi.org\/10.1111\/jnc.14698.","journal-title":"J Neurochem"},{"key":"709_CR84","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1016\/s1353-8020(08)70005-1","volume":"13","author":"Y Tsuboi","year":"2007","unstructured":"Tsuboi Y, Uchikado H, Dickson DW. Neuropathology of Parkinson\u2019s disease dementia and dementia with Lewy bodies with reference to striatal pathology. Parkinsonism Relat Disord. 2007;13:S221\u20134. https:\/\/doi.org\/10.1016\/s1353-8020(08)70005-1.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"709_CR85","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA. Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J Neural Transm. 2018;125(4):615\u201350. https:\/\/doi.org\/10.1007\/s00702-017-1821-9.","journal-title":"J Neural Transm"},{"issue":"4","key":"709_CR86","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0197-4580(96)00005-x","volume":"17","author":"K Double","year":"1996","unstructured":"Double K, Halliday G, Krill J, Harasty J, Cullen K, Brooks W, Creasey H, Broe G. Topography of brain atrophy during normal aging and Alzheimer\u2019s disease. Neurobiol Aging. 1996;17(4):513\u201321. https:\/\/doi.org\/10.1016\/0197-4580(96)00005-x.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"709_CR87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1440-1789.1996.tb00152.x","volume":"16","author":"K Kosaka","year":"1996","unstructured":"Kosaka K, Iseki E, Odawara T, Yamamoto T. Cerebral type of Lewy body disease. Neuropathology. 1996;16(1):32\u20135. https:\/\/doi.org\/10.1111\/j.1440-1789.1996.tb00152.x.","journal-title":"Neuropathology"},{"issue":"6","key":"709_CR88","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1212\/wnl.53.6.1284","volume":"53","author":"E Gomez-Tortosa","year":"1999","unstructured":"Gomez-Tortosa E, Newell K, Irizarry M, Albert M, Growdon J, Hyman BT. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology. 1999;53(6):1284\u20131284. https:\/\/doi.org\/10.1212\/wnl.53.6.1284.","journal-title":"Neurology"},{"issue":"10","key":"709_CR89","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/01.wnl.0000065889.42856.f2","volume":"60","author":"A Merdes","year":"2003","unstructured":"Merdes A, Hansen L, Jeste D, Galasko D, Hofstetter C, Ho G, Thal L, Corey-Bloom J. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 2003;60(10):1586\u201390. https:\/\/doi.org\/10.1212\/01.wnl.0000065889.42856.f2.","journal-title":"Neurology"},{"issue":"11","key":"709_CR90","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","volume":"42","author":"ZS Khachaturian","year":"1985","unstructured":"Khachaturian ZS. Diagnosis of Alzheimer\u2019s disease. Arch Neurol. 1985;42(11):1097\u2013105. https:\/\/doi.org\/10.1001\/archneur.1985.04060100083029.","journal-title":"Arch Neurol"},{"issue":"4","key":"709_CR91","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1749-6632.2000.tb06899.x","volume":"99","author":"E G\u00f3mez-Tortosa","year":"2000","unstructured":"G\u00f3mez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT. \u03b1-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol. 2000;99(4):352\u20137. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06899.x.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"709_CR92","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/s0197-4580(00)00168-8","volume":"21","author":"RT Reid","year":"2000","unstructured":"Reid RT, Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thal LJ. Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer\u2019s disease. Neurobiol Aging. 2000;21(5):741\u20136. https:\/\/doi.org\/10.1016\/s0197-4580(00)00168-8.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"709_CR93","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1212\/wnl.55.9.1278","volume":"55","author":"P Tiraboschi","year":"2000","unstructured":"Tiraboschi P, Hansen L, Alford M, Masliah E, Thal L, Corey-Bloom J. The decline in synapses and cholinergic activity is asynchronous in Alzheimer\u2019s disease. Neurology. 2000;55(9):1278\u201383. https:\/\/doi.org\/10.1212\/wnl.55.9.1278.","journal-title":"Neurology"},{"issue":"10","key":"709_CR94","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1001\/archpsyc.59.10.946","volume":"59","author":"P Tiraboschi","year":"2002","unstructured":"Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry. 2002;59(10):946\u201351. https:\/\/doi.org\/10.1001\/archpsyc.59.10.946.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"709_CR95","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1750-3639.1998.tb00156.x","volume":"8","author":"PG Ince","year":"1998","unstructured":"Ince PG, Perry EK, Morris CM. Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol. 1998;8(2):299\u2013324. https:\/\/doi.org\/10.1111\/j.1750-3639.1998.tb00156.x.","journal-title":"Brain Pathol"},{"issue":"2","key":"709_CR96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00002093-199040200-00003","volume":"4","author":"EK Perry","year":"1990","unstructured":"Perry EK, Marshall E, Perry RH, Irving D, Smith CJ, Blessed G, Fairbairn AF. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord. 1990;4(2):87\u201395.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"709_CR97","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13195-016-0179-9","volume":"8","author":"C Heitz","year":"2016","unstructured":"Heitz C, Noblet V, Phillipps C, Cretin B, Vogt N, Philippi N, Kemp J, de Petigny X, Bilger M, Demuynck C. Cognitive and affective theory of mind in dementia with Lewy bodies and Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2016;8(1):10. https:\/\/doi.org\/10.1186\/s13195-016-0179-9.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"1","key":"709_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0171-4","volume":"8","author":"MH Breitve","year":"2016","unstructured":"Breitve MH, Hynninen MJ, Br\u00f8nnick K, Chwiszczuk LJ, Auestad BH, Aarsland D, Rongve A. A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2016;8(1):1\u20136. https:\/\/doi.org\/10.1186\/s13195-016-0171-4.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"1","key":"709_CR99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13195-018-0356-0","volume":"10","author":"AJ Thomas","year":"2018","unstructured":"Thomas AJ, Mahin-Babaei F, Saidi M, Lett D, Taylor JP, Walker L, Attems J. Improving the identification of dementia with Lewy bodies in the context of an Alzheimer\u2019s-type dementia. Alzheimer\u2019s Res Ther. 2018;10(1):27. https:\/\/doi.org\/10.1186\/s13195-018-0356-0.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"1","key":"709_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/wnl.40.1.1","volume":"40","author":"L Hansen","year":"1990","unstructured":"Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay M, Hofstetter R, Klauber M. The Lewy body variant of Alzheimer\u2019s disease: a clinical and pathologic entity. Neurology. 1990;40(1):1\u20131. https:\/\/doi.org\/10.1212\/wnl.40.1.1.","journal-title":"Neurology"},{"key":"709_CR101","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.07.008","volume":"31","author":"GM Peavy","year":"2016","unstructured":"Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM. Phenotypic differences based on staging of Alzheimer\u2019s neuropathology in autopsy-confirmed dementia with Lewy bodies. Parkinsonism Relat Disord. 2016;31:72\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.008.","journal-title":"Parkinsonism Relat Disord"},{"key":"709_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gaitpost.2016.08.009","volume":"50","author":"NE Fritz","year":"2016","unstructured":"Fritz NE, Kegelmeyer DA, Kloos AD, Linder S, Park A, Kataki M, Adeli A, Agrawal P, Scharre DW, Kostyk SK. Motor performance differentiates individuals with Lewy body dementia, Parkinson\u2019s and Alzheimer\u2019s disease. Gait Posture. 2016;50:1\u20137. https:\/\/doi.org\/10.1016\/j.gaitpost.2016.08.009.","journal-title":"Gait Posture"},{"issue":"1","key":"709_CR103","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00005072-199601000-00005","volume":"55","author":"W Samuel","year":"1996","unstructured":"Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer\u2019s disease. J Neuropathol Exp Neurol. 1996;55(1):44\u201352. https:\/\/doi.org\/10.1097\/00005072-199601000-00005.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"709_CR104","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/brain\/awf033","volume":"125","author":"A Harding","year":"2002","unstructured":"Harding A, Broe G, Halliday G. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain. 2002;125(2):391\u2013403. https:\/\/doi.org\/10.1093\/brain\/awf033.","journal-title":"Brain"},{"issue":"1","key":"709_CR105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s004010051135","volume":"920","author":"E Gomez-Tortosa","year":"2000","unstructured":"Gomez-Tortosa E, Irizarry M, Gomez-Isla T, Hyman B. Clinical and neuropathological correlates of dementia with Lewy bodies. Ann N Y Acad Sci. 2000;920(1):9\u201315. https:\/\/doi.org\/10.1007\/s004010051135.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"709_CR106","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","volume":"69","author":"D Weisman","year":"2007","unstructured":"Weisman D, Cho M, Taylor C, Adame A, Thal L, Hansen L. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology. 2007;69(4):356\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000266626.64913.0f.","journal-title":"Neurology"},{"issue":"6","key":"709_CR107","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.0509567103","volume":"103","author":"CW Shults","year":"2006","unstructured":"Shults CW. Lewy bodies. Proc Natl Acad Sci. 2006;103(6):1661\u20138. https:\/\/doi.org\/10.1073\/pnas.0509567103.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"709_CR108","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding AJ, Halliday GM. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol. 2001;102(4):355\u201363. https:\/\/doi.org\/10.1007\/s004010100390.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"709_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor J-P, Thomas A. Dementia with Lewy bodies: an update and outlook. Mol Neurodegener. 2019;14(1):1\u201318. https:\/\/doi.org\/10.1186\/s13024-019-0306-8.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"709_CR110","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00415-009-5243-y","volume":"256","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA. Formation and development of Lewy pathology: a critical update. J Neurol. 2009;256(3):270\u20139. https:\/\/doi.org\/10.1007\/s00415-009-5243-y.","journal-title":"J Neurol"},{"issue":"3","key":"709_CR111","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","volume":"24","author":"PE Duffy","year":"1965","unstructured":"Duffy PE, Tennyson VM. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson\u2019s disease. J Neuropathol Exp Neurol. 1965;24(3):398\u2013414. https:\/\/doi.org\/10.1097\/00005072-196507000-00003.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"709_CR112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/path.1710990106","volume":"99","author":"S Roy","year":"1969","unstructured":"Roy S, Wolman L. Ultrastructural observations in Parkinsonism. J Pathol. 1969;99(1):39\u201344. https:\/\/doi.org\/10.1002\/path.1710990106.","journal-title":"J Pathol"},{"issue":"10","key":"709_CR113","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1440-1827.1993.tb03230.x","volume":"43","author":"T Fukuda","year":"1993","unstructured":"Fukuda T, Tanaka J, Watabe K, Numoto RT, Minamitani M. Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease. Pathol Int. 1993;43(10):545\u201351. https:\/\/doi.org\/10.1111\/j.1440-1827.1993.tb03230.x.","journal-title":"Pathol Int"},{"issue":"4","key":"709_CR114","first-page":"809","volume":"140","author":"P Galloway","year":"1992","unstructured":"Galloway P, Mulvihill P, Perry G. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol. 1992;140(4):809.","journal-title":"Am J Pathol"},{"key":"709_CR115","first-page":"313","volume":"80","author":"JE Galvin","year":"1999","unstructured":"Galvin JE, Lee V, Schmidt ML, Tu P-H, Iwatsubo T, Trojanowski JQ. Pathobiology of the Lewy body. Adv Neurol. 1999;80:313.","journal-title":"Adv Neurol"},{"issue":"1","key":"709_CR116","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/bf00686786","volume":"75","author":"DW Dickson","year":"1987","unstructured":"Dickson DW, Davies P, Mayeux R, Crystal H, Horoupian D, Thompson A, Goldman J. Diffuse Lewy body disease. Acta Neuropathol. 1987;75(1):8\u201315. https:\/\/doi.org\/10.1007\/bf00686786.","journal-title":"Acta Neuropathol"},{"key":"709_CR117","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4613-0759-4_2","volume-title":"Progress in Parkinson research","author":"LS Forno","year":"1988","unstructured":"Forno LS. The neuropathology of Parkinson\u2019s disease. In: Progress in Parkinson research. Boston: Springer; 1988. p. 11\u201321. https:\/\/doi.org\/10.1007\/978-1-4613-0759-4_2."},{"issue":"9","key":"709_CR118","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1212\/wnl.41.9.1402","volume":"41","author":"DW Dickson","year":"1991","unstructured":"Dickson DW, Ruan D, Crystal H, Mark M, Davies P, Kress Y, Yen S-H. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer\u2019s disease: light and electron microscopic immunocytochemistry of CA2\u20133 neurites specific to DLBD. Neurology. 1991;41(9):1402\u20131402. https:\/\/doi.org\/10.1212\/wnl.41.9.1402.","journal-title":"Neurology"},{"issue":"3","key":"709_CR119","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","volume":"52","author":"MS Pollanen","year":"1993","unstructured":"Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol. 1993;52(3):183\u201391. https:\/\/doi.org\/10.1097\/00005072-199305000-00001.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"709_CR120","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"709_CR121","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0304-3940(99)00208-6","volume":"265","author":"H Braak","year":"1999","unstructured":"Braak H, Sandmann-Keil D, Gai W, Braak E. Extensive axonal Lewy neurites in Parkinson\u2019s disease: a novel pathological feature revealed by \u03b1-synuclein immunocytochemistry. Neurosci Lett. 1999;265(1):67\u20139. https:\/\/doi.org\/10.1016\/s0304-3940(99)00208-6.","journal-title":"Neurosci Lett"},{"issue":"12","key":"709_CR122","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1212\/01.wnl.0000165987.89198.65","volume":"64","author":"ML Kraybill","year":"2005","unstructured":"Kraybill ML, Larson EB, Tsuang D, Teri L, McCormick W, Bowen J, Kukull W, Leverenz J, Cherrier M. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology. 2005;64(12):2069\u201373. https:\/\/doi.org\/10.1212\/01.wnl.0000165987.89198.65.","journal-title":"Neurology"},{"issue":"7","key":"709_CR123","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archneur.55.7.994","volume":"55","author":"DJ Connor","year":"1998","unstructured":"Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal LJ. Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Arch Neurol. 1998;55(7):994\u20131000. https:\/\/doi.org\/10.1001\/archneur.55.7.994.","journal-title":"Arch Neurol"},{"issue":"1","key":"709_CR124","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0046-8177(88)80312-5","volume":"19","author":"M Pappolla","year":"1988","unstructured":"Pappolla M, Shank D, Alzofon J, Dudley A. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson\u2019s disease. Hum Pathol. 1988;19(1):27\u201331. https:\/\/doi.org\/10.1016\/s0046-8177(88)80312-5.","journal-title":"Hum Pathol"},{"issue":"5","key":"709_CR125","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/BF00310030","volume":"83","author":"G Dale","year":"1992","unstructured":"Dale G, Probst A, Luthert P, Martin J, Anderton B, Leigh P. Relationships between Lewy bodies and pale bodies in Parkinson\u2019s disease. Acta Neuropathol. 1992;83(5):525\u20139. https:\/\/doi.org\/10.1007\/BF00310030.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"709_CR126","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/jnnp.52.2.185","volume":"52","author":"W Gibb","year":"1989","unstructured":"Gibb W, Luthert P, Janota I, Lantos P. Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry. 1989;52(2):185\u201392. https:\/\/doi.org\/10.1136\/jnnp.52.2.185.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"709_CR127","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/bf00307643","volume":"89","author":"K Wakabayashi","year":"1995","unstructured":"Wakabayashi K, Hansen LA, Masliah E. Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32. Acta Neuropathol. 1995;89(5):404\u20138. https:\/\/doi.org\/10.1007\/bf00307643.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"709_CR128","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00005072-196104000-00007","volume":"20","author":"H Okazaki","year":"1961","unstructured":"Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol. 1961;20(2):237\u201344. https:\/\/doi.org\/10.1097\/00005072-196104000-00007.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"709_CR129","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/bf00685366","volume":"36","author":"K Kosaka","year":"1976","unstructured":"Kosaka K, Oyanagi S, Matsushita M, Hori A, Iwase S. Presenile dementia with Alzheimer-, Pick-and Lewy-body changes. Acta Neuropathol. 1976;36(3):221\u201333. https:\/\/doi.org\/10.1007\/bf00685366.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"709_CR130","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0006-8993(98)00734-3","volume":"808","author":"K Arima","year":"1998","unstructured":"Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M. Immunoelectron-microscopic demonstration of NACP\/\u03b1-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson\u2019s disease and in dementia with Lewy bodies. Brain Res. 1998;808(1):93\u2013100. https:\/\/doi.org\/10.1016\/s0006-8993(98)00734-3.","journal-title":"Brain Res"},{"issue":"6645","key":"709_CR131","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. \u03b1-Synuclein in Lewy bodies. Nature. 1997;388(6645):839\u201340. https:\/\/doi.org\/10.1038\/42166.","journal-title":"Nature"},{"issue":"1","key":"709_CR132","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0304-3940(97)00891-4","volume":"239","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson\u2019s disease. Neurosci Lett. 1997;239(1):45\u20138. https:\/\/doi.org\/10.1016\/s0304-3940(97)00891-4.","journal-title":"Neurosci Lett"},{"issue":"4","key":"709_CR133","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","volume":"57","author":"MC Irizarry","year":"1998","unstructured":"Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson\u2019s disease and cortical Lewy body disease contain \u03b1-synuclein immunoreactivity. J Neuropathol Exp Neurol. 1998;57(4):334\u20137. https:\/\/doi.org\/10.1097\/00005072-199804000-00005.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"50","key":"709_CR134","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1073\/pnas.1704351114","volume":"114","author":"R Rott","year":"2017","unstructured":"Rott R, Szargel R, Shani V, Hamza H, Savyon M, Abd Elghani F, Bandopadhyay R, Engelender S. SUMOylation and ubiquitination reciprocally regulate \u03b1-synuclein degradation and pathological aggregation. Proc Natl Acad Sci. 2017;114(50):13176\u201381. https:\/\/doi.org\/10.1073\/pnas.1704351114.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"709_CR135","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M. Accumulation of phosphorylated \u03b1-synuclein in aging human brain. J Neuropathol Exp Neurol. 2003;62(6):644\u201354. https:\/\/doi.org\/10.1093\/jnen\/62.6.644.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"709_CR136","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.expneurol.2007.11.019","volume":"210","author":"K Obi","year":"2008","unstructured":"Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, Mizuno Y, Mochizuki H. Relationship of phosphorylated \u03b1-synuclein and tau accumulation to A\u03b2 deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol. 2008;210(2):409\u201320. https:\/\/doi.org\/10.1016\/j.expneurol.2007.11.019.","journal-title":"Exp Neurol"},{"issue":"1","key":"709_CR137","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/path.1711550105","volume":"155","author":"J Lowe","year":"1988","unstructured":"Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson\u2019s disease, Pick\u2019s disease, and Alzheimer\u2019s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol. 1988;155(1):9\u201315. https:\/\/doi.org\/10.1002\/path.1711550105.","journal-title":"J Pathol"},{"issue":"12","key":"709_CR138","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I. Morphogenesis of Lewy bodies: dissimilar incorporation of \u03b1-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol. 2003;62(12):1241\u201353. https:\/\/doi.org\/10.1093\/jnen\/62.12.1241.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"709_CR139","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","volume":"17","author":"JB Leverenz","year":"2007","unstructured":"Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D. Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathol. 2007;17(2):139\u201345. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00048.x.","journal-title":"Brain Pathol"},{"issue":"2","key":"709_CR140","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1006\/exnr.2000.7527","volume":"166","author":"W Gai","year":"2000","unstructured":"Gai W, Yuan H, Li X, Power J, Blumbergs P, Jensen P. In situ and in vitro study of colocalization and segregation of \u03b1-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol. 2000;166(2):324\u201333. https:\/\/doi.org\/10.1006\/exnr.2000.7527.","journal-title":"Exp Neurol"},{"issue":"7","key":"709_CR141","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, Casta\u00f1o-D\u00edez D, Schweighauser G, Graff-Meyer A, Goldie KN. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci. 2019;22(7):1099\u2013109. https:\/\/doi.org\/10.1038\/s41593-019-0423-2.","journal-title":"Nat Neurosci"},{"issue":"3","key":"709_CR142","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/bf00688674","volume":"34","author":"LS Forno","year":"1976","unstructured":"Forno LS, Norville RL. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol. 1976;34(3):183\u201397. https:\/\/doi.org\/10.1007\/bf00688674.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"709_CR143","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/bf00342349","volume":"228","author":"K Ikeda","year":"1980","unstructured":"Ikeda K, Hori A, Bode G. Progressive dementia with \u2018diffuse Lewy-type inclusions\u2019 in cerebral cortex. Arch Psychiatr Nervenkr. 1980;228(3):243\u20138. https:\/\/doi.org\/10.1007\/bf00342349.","journal-title":"Arch Psychiatr Nervenkr"},{"issue":"3","key":"709_CR144","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/bf00707105","volume":"49","author":"S Yagishita","year":"1980","unstructured":"Yagishita S, Itoh Y, Amano N, Nakano T. Atypical senile dementia with widespread Lewy type inclusion in the cerebral cortex. Acta Neuropathol. 1980;49(3):187\u201391. https:\/\/doi.org\/10.1007\/bf00707105.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"709_CR145","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/bf00689998","volume":"53","author":"M Tomonaga","year":"1981","unstructured":"Tomonaga M. Neurofibrillary tangles and Lewy bodies in the locus ceruleus neurons of the aged brain. Acta Neuropathol. 1981;53(2):165\u20138. https:\/\/doi.org\/10.1007\/bf00689998.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"709_CR146","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","volume":"62","author":"T Ishizawa","year":"2003","unstructured":"Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol. 2003;62(4):389\u201397. https:\/\/doi.org\/10.1093\/jnen\/62.4.389.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"709_CR147","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuroscience.2008.01.030","volume":"152","author":"G Muntane","year":"2008","unstructured":"Muntane G, Dalfo E, Martinez A, Ferrer I. Phosphorylation of tau and \u03b1-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer\u2019s disease, and in Parkinson\u2019s disease and related \u03b1-synucleinopathies. Neuroscience. 2008;152(4):913\u201323. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.01.030.","journal-title":"Neuroscience"},{"issue":"3","key":"709_CR148","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ana.21446","volume":"64","author":"T Peuralinna","year":"2008","unstructured":"Peuralinna T, Oinas M, Polvikoski T, Paetau A, Sulkava R, Niinist\u00f6 L, Kalimo H, Hernandez D, Hardy J, Singleton A. Neurofibrillary tau pathology modulated by genetic variation of \u03b1-synuclein. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc. 2008;64(3):348\u201352. https:\/\/doi.org\/10.1002\/ana.21446.","journal-title":"Ann Neurol Off J Am Neurol Assoc Child Neurol Soc"},{"issue":"1","key":"709_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2001-3-1-reviews3002","volume":"3","author":"JM George","year":"2001","unstructured":"George JM. The synucleins. Genome Biol. 2001;3(1):1\u20136. https:\/\/doi.org\/10.1186\/gb-2001-3-1-reviews3002.","journal-title":"Genome Biol"},{"issue":"9","key":"709_CR150","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1101\/gr.8.9.871","volume":"8","author":"C Lavedan","year":"1998","unstructured":"Lavedan C. The synuclein family. Genome Res. 1998;8(9):871\u201380. https:\/\/doi.org\/10.1101\/gr.8.9.871.","journal-title":"Genome Res"},{"issue":"23","key":"709_CR151","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"90","author":"K U\u00e9da","year":"1993","unstructured":"U\u00e9da K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero D, Kondo J, Ihara Y, Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci. 1993;90(23):11282\u20136. https:\/\/doi.org\/10.1073\/pnas.90.23.11282.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"709_CR152","doi-asserted-by":"publisher","first-page":"9595","DOI":"10.1074\/jbc.m411805200","volume":"280","author":"TS Ulmer","year":"2005","unstructured":"Ulmer TS, Bax A, Cole NB, Nussbaum RL. Structure and dynamics of micelle-bound human \u03b1-synuclein. J Biol Chem. 2005;280(10):9595\u2013603. https:\/\/doi.org\/10.1074\/jbc.m411805200.","journal-title":"J Biol Chem"},{"issue":"4","key":"709_CR153","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","volume":"307","author":"D Eliezer","year":"2001","unstructured":"Eliezer D, Kutluay E, Bussell R Jr, Browne G. Conformational properties of \u03b1-synuclein in its free and lipid-associated states. J Mol Biol. 2001;307(4):1061\u201373. https:\/\/doi.org\/10.1006\/jmbi.2001.4538.","journal-title":"J Mol Biol"},{"issue":"2","key":"709_CR154","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George JM, Jin H, Woods WS, Clayton DF. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron. 1995;15(2):361\u201372. https:\/\/doi.org\/10.1016\/0896-6273(95)90040-3.","journal-title":"Neuron"},{"issue":"6","key":"709_CR155","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0166-2236(97)01213-7","volume":"21","author":"DF Clayton","year":"1998","unstructured":"Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 1998;21(6):249\u201354. https:\/\/doi.org\/10.1016\/s0166-2236(97)01213-7.","journal-title":"Trends Neurosci"},{"issue":"16","key":"709_CR156","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM. Stabilization of \u03b1-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 1998;273(16):9443\u20139. https:\/\/doi.org\/10.1074\/jbc.273.16.9443.","journal-title":"J Biol Chem"},{"issue":"22","key":"709_CR157","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.1073\/pnas.0400553101","volume":"101","author":"CC Jao","year":"2004","unstructured":"Jao CC, Der-Sarkissian A, Chen J, Langen R. Structure of membrane-bound \u03b1-synuclein studied by site-directed spin labeling. Proc Natl Acad Sci. 2004;101(22):8331\u20136. https:\/\/doi.org\/10.1073\/pnas.0400553101.","journal-title":"Proc Natl Acad Sci"},{"issue":"41","key":"709_CR158","doi-asserted-by":"publisher","first-page":"40186","DOI":"10.1074\/jbc.m305326200","volume":"278","author":"M Zhu","year":"2003","unstructured":"Zhu M, Li J, Fink AL. The association of \u03b1-synuclein with membranes affects bilayer structure, stability, and fibril formation. J Biol Chem. 2003;278(41):40186\u201397. https:\/\/doi.org\/10.1074\/jbc.m305326200.","journal-title":"J Biol Chem"},{"issue":"8","key":"709_CR159","doi-asserted-by":"publisher","first-page":"10153","DOI":"10.1021\/acsnano.0c03420","volume":"14","author":"SM McClain","year":"2020","unstructured":"McClain SM, Ojoawo AM, Lin W, Rienstra CM, Murphy CJ. Interaction of Alpha-synuclein and its mutants with rigid lipid vesicle mimics of varying surface curvature. ACS Nano. 2020;14(8):10153\u201367. https:\/\/doi.org\/10.1021\/acsnano.0c03420.","journal-title":"ACS Nano"},{"issue":"40","key":"709_CR160","doi-asserted-by":"publisher","first-page":"21110","DOI":"10.1074\/jbc.m116.726612","volume":"291","author":"A Iyer","year":"2016","unstructured":"Iyer A, Roeters SJ, Schilderink N, Hommersom B, Heeren RM, Woutersen S, Claessens MM, Subramaniam V. The impact of N-terminal acetylation of \u03b1-synuclein on phospholipid membrane binding and fibril structure. J Biol Chem. 2016;291(40):21110\u201322. https:\/\/doi.org\/10.1074\/jbc.m116.726612.","journal-title":"J Biol Chem"},{"issue":"28","key":"709_CR161","doi-asserted-by":"publisher","first-page":"11195","DOI":"10.1074\/jbc.ra118.002780","volume":"293","author":"EI O'Leary","year":"2018","unstructured":"O\u2019Leary EI, Jiang Z, Strub M-P, Lee JC. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated \u03b1-synuclein. J Biol Chem. 2018;293(28):11195\u2013205. https:\/\/doi.org\/10.1074\/jbc.ra118.002780.","journal-title":"J Biol Chem"},{"issue":"6","key":"709_CR162","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, Weir D, Thompson C, Szu-Tu C, Trinh J. Alpha-synuclein p. H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord. 2013;28(6):811\u20133. https:\/\/doi.org\/10.1002\/mds.25421.","journal-title":"Mov Disord"},{"issue":"2","key":"709_CR163","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S, Przuntek H, Epplen JT, Schols L, Riess O. AlaSOPro mutation in the gene encoding \u03b1-synuclein in Parkinson\u2019s disease. Nat Genet. 1998;18(2):106\u20138. https:\/\/doi.org\/10.1038\/ng0298-106.","journal-title":"Nat Genet"},{"issue":"4","key":"709_CR164","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, Bousset L, Honor\u00e9 A, Rozas N, Pieri L, Madiona K, D\u00fcrr A, Melki R. G51D \u03b1-synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome. Ann Neurol. 2013;73(4):459\u201371. https:\/\/doi.org\/10.1002\/ana.23894.","journal-title":"Ann Neurol"},{"issue":"5321","key":"709_CR165","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276(5321):2045\u20137. https:\/\/doi.org\/10.1126\/science.276.5321.2045.","journal-title":"Science"},{"issue":"11","key":"709_CR166","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/wnl.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis C, Dudzik CG, Brier T, MacKay DS, Cooper JM, Millhauser GL, Houlden H, Schapira AH. A novel \u03b1-synuclein missense mutation in Parkinson disease. Neurology. 2013;80(11):1062\u20134. https:\/\/doi.org\/10.1212\/wnl.0b013e31828727ba.","journal-title":"Neurology"},{"key":"709_CR167","doi-asserted-by":"publisher","unstructured":"Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, Tienari PJ, P\u00f6yh\u00f6nen M, Paetau A. A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging. 2014;35(9):2180.e2181\u20132180, e2185. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.024.","DOI":"10.1016\/j.neurobiolaging.2014.03.024"},{"issue":"1","key":"709_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16564-3","volume":"11","author":"AD Stephens","year":"2020","unstructured":"Stephens AD, Zacharopoulou M, Moons R, Fusco G, Seetaloo N, Chiki A, Woodhams PJ, Mela I, Lashuel HA, Phillips JJ. Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity. Nat Commun. 2020;11(1):1\u201315. https:\/\/doi.org\/10.1038\/s41467-020-16564-3.","journal-title":"Nat Commun"},{"issue":"41","key":"709_CR169","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1021\/bi5010365","volume":"53","author":"D Ghosh","year":"2014","unstructured":"Ghosh D, Sahay S, Ranjan P, Salot S, Mohite GM, Singh PK, Dwivedi S, Carvalho E, Banerjee R, Kumar A. The newly discovered Parkinson\u2019s disease associated Finnish mutation (A53E) attenuates \u03b1-synuclein aggregation and membrane binding. Biochemistry. 2014;53(41):6419\u201321. https:\/\/doi.org\/10.1021\/bi5010365.","journal-title":"Biochemistry"},{"issue":"12","key":"709_CR170","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","volume":"274","author":"BI Giasson","year":"1999","unstructured":"Giasson BI, Uryu K, Trojanowski JQ, Lee VM-Y. Mutant and wild type human \u03b1-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem. 1999;274(12):7619\u201322. https:\/\/doi.org\/10.1074\/jbc.274.12.7619.","journal-title":"J Biol Chem"},{"issue":"9","key":"709_CR171","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.1074\/jbc.m411638200","volume":"280","author":"EA Greenbaum","year":"2005","unstructured":"Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, Englander SW, Axelsen PH, Giasson BI. The E46K mutation in \u03b1-synuclein increases amyloid fibril formation. J Biol Chem. 2005;280(9):7800\u20137. https:\/\/doi.org\/10.1074\/jbc.m411638200.","journal-title":"J Biol Chem"},{"issue":"12","key":"709_CR172","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/cdd.2015.79","volume":"22","author":"A Mahul-Mellier","year":"2015","unstructured":"Mahul-Mellier A, Vercruysse F, Maco B, Ait-Bouziad N, De Roo M, Muller D, Lashuel H. Fibril growth and seeding capacity play key roles in \u03b1-synuclein-mediated apoptotic cell death. Cell Death Differ. 2015;22(12):2107\u201322. https:\/\/doi.org\/10.1038\/cdd.2015.79.","journal-title":"Cell Death Differ"},{"issue":"14","key":"709_CR173","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","volume":"274","author":"L Narhi","year":"1999","unstructured":"Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P. Both familial Parkinson\u2019s disease mutations accelerate \u03b1-synuclein aggregation. J Biol Chem. 1999;274(14):9843\u20136. https:\/\/doi.org\/10.1074\/jbc.274.14.9843.","journal-title":"J Biol Chem"},{"issue":"3","key":"709_CR174","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41594-020-0384-x","volume":"27","author":"CP Doherty","year":"2020","unstructured":"Doherty CP, Ulamec SM, Maya-Martinez R, Good SC, Makepeace J, Khan GN, van Oosten-Hawle P, Radford SE, Brockwell DJ. A short motif in the N-terminal region of \u03b1-synuclein is critical for both aggregation and function. Nat Struct Mol Biol. 2020;27(3):249\u201359. https:\/\/doi.org\/10.1038\/s41594-020-0384-x.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"709_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-016-0402-8","volume":"4","author":"DF L\u00e1zaro","year":"2016","unstructured":"L\u00e1zaro DF, Dias MC, Carija A, Navarro S, Madaleno CS, Tenreiro S, Ventura S, Outeiro TF. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Acta Neuropathol Commun. 2016;4(1):1\u201315. https:\/\/doi.org\/10.1186\/s40478-016-0402-8.","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"709_CR176","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1073\/pnas.1917914117","volume":"117","author":"DR Boyer","year":"2020","unstructured":"Boyer DR, Li B, Sun C, Fan W, Zhou K, Hughes MP, Sawaya MR, Jiang L, Eisenberg DS. The \u03b1-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure. Proc Natl Acad Sci. 2020;117(7):3592\u2013602. https:\/\/doi.org\/10.1073\/pnas.1917914117.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"709_CR177","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/s0002-9440(10)64777-3","volume":"156","author":"M Hashimoto","year":"2000","unstructured":"Hashimoto M, Takenouchi T, Mallory M, Masliah E, Takeda A. The role of NAC in amyloidogenesis in Alzheimer\u2019s disease. Am J Pathol. 2000;156(2):734. https:\/\/doi.org\/10.1016\/s0002-9440(10)64777-3.","journal-title":"Am J Pathol"},{"issue":"1\u20132","key":"709_CR178","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0014-5793(98)01419-7","volume":"440","author":"OM El-Agnaf","year":"1998","unstructured":"El-Agnaf OM, Jakes R, Curran MD, Wallace A. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of \u03b1-synuclein protein implicated in Parkinson\u2019s disease. FEBS Lett. 1998;440(1\u20132):67\u201370. https:\/\/doi.org\/10.1016\/s0014-5793(98)01419-7.","journal-title":"FEBS Lett"},{"issue":"47","key":"709_CR179","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM-Y. Exogenous \u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci. 2009;106(47):20051\u20136. https:\/\/doi.org\/10.1073\/pnas.0908005106.","journal-title":"Proc Natl Acad Sci"},{"key":"709_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103389","volume":"94","author":"P Ryan","year":"2020","unstructured":"Ryan P, Xu M-M, Davey AK, Kassiou M, Mellick GD, Rudrawar S. O-GlcNAcylation of truncated NAC segment alters peptide-dependent effects on \u03b1-synuclein aggregation. Bioorg Chem. 2020;94: 103389. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103389.","journal-title":"Bioorg Chem"},{"issue":"1","key":"709_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-75361-6","volume":"10","author":"T Srivastava","year":"2020","unstructured":"Srivastava T, Raj R, Dubey A, Kumar D, Chaturvedi RK, Sharma SK, Priya S. Fast kinetics of environmentally induced \u03b1-synuclein aggregation mediated by structural alteration in NAC region and result in structure dependent cytotoxicity. Sci Rep. 2020;10(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-020-75361-6.","journal-title":"Sci Rep"},{"issue":"4","key":"709_CR182","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.m008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IV, Trojanowski JQ, Lee VM-Y. A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly. J Biol Chem. 2001;276(4):2380\u20136. https:\/\/doi.org\/10.1074\/jbc.m008919200.","journal-title":"J Biol Chem"},{"issue":"3","key":"709_CR183","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/1074-5521(95)90071-3","volume":"2","author":"H Han","year":"1995","unstructured":"Han H, Weinreb PH, Lansbury PT Jr. The core Alzheimer\u2019s peptide NAC forms amyloid fibrils which seed and are seeded by \u03b2-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol. 1995;2(3):163\u20139. https:\/\/doi.org\/10.1016\/1074-5521(95)90071-3.","journal-title":"Chem Biol"},{"issue":"7570","key":"709_CR184","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature15368","volume":"525","author":"JA Rodriguez","year":"2015","unstructured":"Rodriguez JA, Ivanova MI, Sawaya MR, Cascio D, Reyes FE, Shi D, Sangwan S, Guenther EL, Johnson LM, Zhang M. Structure of the toxic core of \u03b1-synuclein from invisible crystals. Nature. 2015;525(7570):486\u201390. https:\/\/doi.org\/10.1038\/nature15368.","journal-title":"Nature"},{"key":"709_CR185","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ejmech.2016.01.044","volume":"121","author":"L Xu","year":"2016","unstructured":"Xu L, Nussinov R, Ma B. Coupling of the non-amyloid-component (NAC) domain and the KTK (E\/Q) GV repeats stabilize the \u03b1-synuclein fibrils. Eur J Med Chem. 2016;121:841\u201350. https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.044.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"709_CR186","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jmb.2011.05.046","volume":"411","author":"K Levitan","year":"2011","unstructured":"Levitan K, Chereau D, Cohen SI, Knowles TP, Dobson CM, Fink AL, Anderson JP, Goldstein JM, Millhauser GL. Conserved C-terminal charge exerts a profound influence on the aggregation rate of \u03b1-synuclein. J Mol Biol. 2011;411(2):329\u201333. https:\/\/doi.org\/10.1016\/j.jmb.2011.05.046.","journal-title":"J Mol Biol"},{"issue":"43","key":"709_CR187","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1021\/bi1010927","volume":"49","author":"J Meuvis","year":"2010","unstructured":"Meuvis J, Gerard M, Desender L, Baekelandt V, Engelborghs Y. The conformation and the aggregation kinetics of \u03b1-synuclein depend on the proline residues in its C-terminal region. Biochemistry. 2010;49(43):9345\u201352. https:\/\/doi.org\/10.1021\/bi1010927.","journal-title":"Biochemistry"},{"issue":"2","key":"709_CR188","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1515\/revneuro-2012-0071","volume":"24","author":"H Sato","year":"2013","unstructured":"Sato H, Kato T, Arawaka S. The role of Ser129 phosphorylation of \u03b1-synuclein in neurodegeneration of Parkinson\u2019s disease: a review of in vivo models. Rev Neurosci. 2013;24(2):115\u201323. https:\/\/doi.org\/10.1515\/revneuro-2012-0071.","journal-title":"Rev Neurosci"},{"key":"709_CR189","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0079-6123(10)83007-9","volume-title":"Progress in brain research","author":"A Oueslati","year":"2010","unstructured":"Oueslati A, Fournier M, Lashuel HA. Role of post-translational modifications in modulating the structure, function and toxicity of \u03b1-synuclein: implications for Parkinson\u2019s disease pathogenesis and therapies. In: Progress in brain research, vol. 183. Amsterdam: Elsevier; 2010. p. 115\u201345. https:\/\/doi.org\/10.1016\/s0079-6123(10)83007-9."},{"issue":"51","key":"709_CR190","doi-asserted-by":"publisher","first-page":"16233","DOI":"10.1021\/bi048453u","volume":"43","author":"W Hoyer","year":"2004","unstructured":"Hoyer W, Cherny D, Subramaniam V, Jovin TM. Impact of the acidic C-terminal region comprising amino acids 109\u2013140 on \u03b1-synuclein aggregation in vitro. Biochemistry. 2004;43(51):16233\u201342. https:\/\/doi.org\/10.1021\/bi048453u.","journal-title":"Biochemistry"},{"issue":"3","key":"709_CR191","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0304-3940(02)00154-4","volume":"323","author":"PJ McLean","year":"2002","unstructured":"McLean PJ, Hyman BT. An alternatively spliced form of rodent \u03b1-synuclein forms intracellular inclusions in vitro: role of the carboxy-terminus in \u03b1-synuclein aggregation. Neurosci Lett. 2002;323(3):219\u201323. https:\/\/doi.org\/10.1016\/s0304-3940(02)00154-4.","journal-title":"Neurosci Lett"},{"issue":"28","key":"709_CR192","doi-asserted-by":"publisher","first-page":"8530","DOI":"10.1021\/bi027363r","volume":"42","author":"IV Murray","year":"2003","unstructured":"Murray IV, Giasson BI, Quinn SM, Koppaka V, Axelsen PH, Ischiropoulos H, Trojanowski JQ, Lee VM-Y. Role of \u03b1-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry. 2003;42(28):8530\u201340. https:\/\/doi.org\/10.1021\/bi027363r.","journal-title":"Biochemistry"},{"issue":"1","key":"709_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03111-4","volume":"9","author":"J Lautenschl\u00e4ger","year":"2018","unstructured":"Lautenschl\u00e4ger J, Stephens AD, Fusco G, Str\u00f6hl F, Curry N, Zacharopoulou M, Michel CH, Laine R, Nespovitaya N, Fantham M. C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction. Nat Commun. 2018;9(1):1\u201313. https:\/\/doi.org\/10.1038\/s41467-018-03111-4.","journal-title":"Nat Commun"},{"issue":"10","key":"709_CR194","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/j.bpj.2017.08.027","volume":"113","author":"K Afitska","year":"2017","unstructured":"Afitska K, Fucikova A, Shvadchak VV, Yushchenko DA. Modification of C terminus provides new insights into the mechanism of \u03b1-synuclein aggregation. Biophys J. 2017;113(10):2182\u201391. https:\/\/doi.org\/10.1016\/j.bpj.2017.08.027.","journal-title":"Biophys J"},{"issue":"1","key":"709_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-66200-9","volume":"10","author":"J Torpey","year":"2020","unstructured":"Torpey J, Madine J, Wood A, Lian L-Y. Cyclophilin D binds to the acidic C-terminus region of \u03b1-synuclein and affects its aggregation characteristics. Sci Rep. 2020;10(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-020-66200-9.","journal-title":"Sci Rep"},{"issue":"8","key":"709_CR196","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/jneurosci.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988;8(8):2804\u201315. https:\/\/doi.org\/10.1523\/jneurosci.08-08-02804.1988.","journal-title":"J Neurosci"},{"issue":"2","key":"709_CR197","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-x","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, De Silva HR, Kittel A, Saitoh T. The precursor protein of non-A\u03b2 component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14(2):467\u201375. https:\/\/doi.org\/10.1016\/0896-6273(95)90302-x.","journal-title":"Neuron"},{"issue":"1","key":"709_CR198","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0165-3806(96)00210-6","volume":"99","author":"GS Withers","year":"1997","unstructured":"Withers GS, George JM, Banker GA, Clayton DF. Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. Dev Brain Res. 1997;99(1):87\u201394. https:\/\/doi.org\/10.1016\/s0165-3806(96)00210-6.","journal-title":"Dev Brain Res"},{"issue":"7","key":"709_CR199","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","volume":"99","author":"T Bartels","year":"2010","unstructured":"Bartels T, Ahlstrom LS, Leftin A, Kamp F, Haass C, Brown MF, Beyer K. The N-terminus of the intrinsically disordered protein \u03b1-synuclein triggers membrane binding and helix folding. Biophys J. 2010;99(7):2116\u201324. https:\/\/doi.org\/10.1016\/j.bpj.2010.06.035.","journal-title":"Biophys J"},{"issue":"1","key":"709_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-57023-4","volume":"10","author":"M Runfola","year":"2020","unstructured":"Runfola M, De Simone A, Vendruscolo M, Dobson CM, Fusco G. The n-terminal acetylation of \u03b1-synuclein changes the affinity for lipid membranes but not the structural properties of the bound state. Sci Rep. 2020;10(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-019-57023-4.","journal-title":"Sci Rep"},{"issue":"30","key":"709_CR201","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin DL, Troyer MD, Nakamura K, Kubo S-I, Anthony MD, Edwards RH. Lipid rafts mediate the synaptic localization of \u03b1-synuclein. J Neurosci. 2004;24(30):6715\u201323. https:\/\/doi.org\/10.1523\/JNEUROSCI.1594-04.2004.","journal-title":"J Neurosci"},{"issue":"17","key":"709_CR202","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1523\/jneurosci.20-17-06365.2000","volume":"20","author":"PJ Kahle","year":"2000","unstructured":"Kahle PJ, Neumann M, Ozmen L, M\u00fcller V, Jacobsen H, Schindzielorz A, Okochi M, Leimer U, van der Putten H, Probst A. Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant \u03b1-synuclein in human and transgenic mouse brain. J Neurosci. 2000;20(17):6365\u201373. https:\/\/doi.org\/10.1523\/jneurosci.20-17-06365.2000.","journal-title":"J Neurosci"},{"key":"709_CR203","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1914670117","author":"JK Hannestad","year":"2020","unstructured":"Hannestad JK, Rocha S, Agnarsson B, Zhdanov VP, Wittung-Stafshede P, H\u00f6\u00f6k F. Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric \u03b1-synuclein. Proc Natl Acad Sci. 2020. https:\/\/doi.org\/10.1073\/pnas.1914670117.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"709_CR204","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010589","volume":"5","author":"VK Unni","year":"2010","unstructured":"Unni VK, Weissman TA, Rockenstein E, Masliah E, McLean PJ, Hyman BT. In vivo imaging of \u03b1-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility. PLoS ONE. 2010;5(5): e10589. https:\/\/doi.org\/10.1371\/journal.pone.0010589.","journal-title":"PLoS ONE"},{"issue":"4","key":"709_CR205","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/jmbi.2001.5269","volume":"315","author":"E Jo","year":"2002","unstructured":"Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE. Defective membrane interactions of familial Parkinson\u2019s disease mutant A30P \u03b1-synuclein. J Mol Biol. 2002;315(4):799\u2013807. https:\/\/doi.org\/10.1006\/jmbi.2001.5269.","journal-title":"J Mol Biol"},{"issue":"41","key":"709_CR206","doi-asserted-by":"publisher","first-page":"26292","DOI":"10.1074\/jbc.273.41.26292","volume":"273","author":"PH Jensen","year":"1998","unstructured":"Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M. Binding of \u03b1-synuclein to brain vesicles is abolished by familial Parkinson\u2019s disease mutation. J Biol Chem. 1998;273(41):26292\u20134. https:\/\/doi.org\/10.1074\/jbc.273.41.26292.","journal-title":"J Biol Chem"},{"issue":"49","key":"709_CR207","doi-asserted-by":"publisher","first-page":"42603","DOI":"10.1074\/jbc.m111.271130","volume":"286","author":"MB Jensen","year":"2011","unstructured":"Jensen MB, Bhatia VK, Jao CC, Rasmussen JE, Pedersen SL, Jensen KJ, Langen R, Stamou D. Membrane curvature sensing by amphipathic helices a single liposome study using \u03b1-synuclein and annexin B12. J Biol Chem. 2011;286(49):42603\u201314. https:\/\/doi.org\/10.1074\/jbc.m111.271130.","journal-title":"J Biol Chem"},{"issue":"7","key":"709_CR208","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","volume":"99","author":"ER Middleton","year":"2010","unstructured":"Middleton ER, Rhoades E. Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles. Biophys J. 2010;99(7):2279\u201388. https:\/\/doi.org\/10.1016\/j.bpj.2010.07.056.","journal-title":"Biophys J"},{"key":"709_CR209","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000107r","author":"E Cholak","year":"2020","unstructured":"Cholak E, Bugge K, Khondker A, Gauger K, Pedraz-Cuesta E, Pedersen ME, Bucciarelli S, Vestergaard B, Pedersen SF, Rheinst\u00e4dter MC. Avidity within the N-terminal anchor drives \u03b1-synuclein membrane interaction and insertion. FASEB J. 2020. https:\/\/doi.org\/10.1096\/fj.202000107r.","journal-title":"FASEB J"},{"issue":"1","key":"709_CR210","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1083\/jcb.201011118","volume":"194","author":"IM Pranke","year":"2011","unstructured":"Pranke IM, Morello V, Bigay J, Gibson K, Verbavatz J-M, Antonny B, Jackson CL. \u03b1-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J Cell Biol. 2011;194(1):89\u2013103. https:\/\/doi.org\/10.1083\/jcb.201011118.","journal-title":"J Cell Biol"},{"issue":"21","key":"709_CR211","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.1074\/jbc.ra118.001986","volume":"293","author":"SMM Badawy","year":"2018","unstructured":"Badawy SMM, Okada T, Kajimoto T, Hirase M, Matovelo SA, Nakamura S, Yoshida D, Ijuin T, Nakamura S-I. Extracellular \u03b1-synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling. J Biol Chem. 2018;293(21):8208\u201316. https:\/\/doi.org\/10.1074\/jbc.ra118.001986.","journal-title":"J Biol Chem"},{"key":"709_CR212","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ebiom.2016.03.038","volume":"7","author":"M Emanuele","year":"2016","unstructured":"Emanuele M, Esposito A, Camerini S, Antonucci F, Ferrara S, Seghezza S, Catelani T, Crescenzi M, Marotta R, Canale C. Exogenous alpha-synuclein alters pre-and post-synaptic activity by fragmenting lipid rafts. EBioMedicine. 2016;7:191\u2013204. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.038.","journal-title":"EBioMedicine"},{"issue":"3","key":"709_CR213","doi-asserted-by":"publisher","first-page":"391a","DOI":"10.1016\/j.bpj.2019.11.2225","volume":"118","author":"L Casalis","year":"2020","unstructured":"Casalis L, Parisse P, Perissinotto F, Rondelli VM, Scaini D, Legname GA, Stani C. Interaction of alpha-synuclein with raft containing model lipid membranes: morphology and structure. Biophys J. 2020;118(3):391a. https:\/\/doi.org\/10.1016\/j.bpj.2019.11.2225.","journal-title":"Biophys J"},{"issue":"3","key":"709_CR214","doi-asserted-by":"publisher","first-page":"244a","DOI":"10.1016\/j.bpj.2017.11.1360","volume":"114","author":"L Casalis","year":"2018","unstructured":"Casalis L, Perissinotto F, Scaini D. Iron mediated interaction of alpha synuclein with lipid rafts in model membrane systems. Biophys J. 2018;114(3):244a. https:\/\/doi.org\/10.1016\/j.bpj.2017.11.1360.","journal-title":"Biophys J"},{"issue":"36","key":"709_CR215","doi-asserted-by":"publisher","first-page":"31664","DOI":"10.1074\/jbc.m504894200","volume":"280","author":"S-I Kubo","year":"2005","unstructured":"Kubo S-I, Nemani VM, Chalkley RJ, Anthony MD, Hattori N, Mizuno Y, Edwards RH, Fortin DL. A combinatorial code for the interaction of \u03b1-synuclein with membranes. J Biol Chem. 2005;280(36):31664\u201372. https:\/\/doi.org\/10.1074\/jbc.m504894200.","journal-title":"J Biol Chem"},{"issue":"16","key":"709_CR216","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1016\/j.jmb.2013.04.002","volume":"425","author":"A Leftin","year":"2013","unstructured":"Leftin A, Job C, Beyer K, Brown MF. Solid-state 13C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein \u03b1-synuclein. J Mol Biol. 2013;425(16):2973\u201387. https:\/\/doi.org\/10.1016\/j.jmb.2013.04.002.","journal-title":"J Mol Biol"},{"issue":"16","key":"709_CR217","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1073\/pnas.171300598","volume":"98","author":"R Sharon","year":"2001","unstructured":"Sharon R, Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ. \u03b1-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci. 2001;98(16):9110\u20135. https:\/\/doi.org\/10.1073\/pnas.171300598.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"709_CR218","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.2353\/2Fajpath.2007.070373","volume":"171","author":"K Assayag","year":"2007","unstructured":"Assayag K, Yakunin E, Loeb V, Selkoe DJ, Sharon R. Polyunsaturated fatty acids induce \u03b1-synuclein-related pathogenic changes in neuronal cells. Am J Pathol. 2007;171(6):2000\u201311. https:\/\/doi.org\/10.2353\/2Fajpath.2007.070373.","journal-title":"Am J Pathol"},{"issue":"45","key":"709_CR219","doi-asserted-by":"publisher","first-page":"41958","DOI":"10.1074\/jbc.m105022200","volume":"276","author":"RJ Perrin","year":"2001","unstructured":"Perrin RJ, Woods WS, Clayton DF, George JM. Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J Biol Chem. 2001;276(45):41958\u201362. https:\/\/doi.org\/10.1074\/jbc.m105022200.","journal-title":"J Biol Chem"},{"issue":"4","key":"709_CR220","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ. The formation of highly soluble oligomers of \u03b1-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease. Neuron. 2003;37(4):583\u201395. https:\/\/doi.org\/10.1016\/S0896-6273(03)00024-2.","journal-title":"Neuron"},{"issue":"50","key":"709_CR221","doi-asserted-by":"publisher","first-page":"49874","DOI":"10.1074\/jbc.M309127200","volume":"278","author":"R Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Mirick GE, Serhan CN, Selkoe DJ. Altered fatty acid composition of dopaminergic neurons expressing \u03b1-synuclein and human brains with \u03b1-synucleinopathies. J Biol Chem. 2003;278(50):49874\u201381. https:\/\/doi.org\/10.1074\/jbc.M309127200.","journal-title":"J Biol Chem"},{"issue":"22","key":"709_CR222","doi-asserted-by":"publisher","first-page":"10190","DOI":"10.1128\/mcb.25.22.10190-10201.2005","volume":"25","author":"CE Ellis","year":"2005","unstructured":"Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcel\u00f3-Coblijn GC, Nussbaum RL. Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking \u03b1-synuclein. Mol Cell Biol. 2005;25(22):10190\u2013201. https:\/\/doi.org\/10.1128\/mcb.25.22.10190-10201.2005.","journal-title":"Mol Cell Biol"},{"issue":"23","key":"709_CR223","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1021\/bi0502137","volume":"44","author":"MY Golovko","year":"2005","unstructured":"Golovko MY, Faergeman NJ, Cole NB, Castagnet PI, Nussbaum RL, Murphy EJ. \u03b1-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of \u03b1-synuclein palmitate binding. Biochemistry. 2005;44(23):8251\u20139. https:\/\/doi.org\/10.1021\/bi0502137.","journal-title":"Biochemistry"},{"issue":"22","key":"709_CR224","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1021\/bi0600289","volume":"45","author":"MY Golovko","year":"2006","unstructured":"Golovko MY, Rosenberger TA, F\u00e6rgeman NJ, Feddersen S, Cole NB, Pribill I, Berger J, Nussbaum RL, Murphy EJ. Acyl-CoA synthetase activity links wild-type but not mutant \u03b1-synuclein to brain arachidonate metabolism. Biochemistry. 2006;45(22):6956\u201366. https:\/\/doi.org\/10.1021\/bi0600289.","journal-title":"Biochemistry"},{"issue":"1","key":"709_CR225","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1471-4159.2006.04357.x","volume":"101","author":"MY Golovko","year":"2007","unstructured":"Golovko MY, Rosenberger TA, Feddersen S, F\u00e6rgeman NJ, Murphy EJ. \u03b1-Synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. J Neurochem. 2007;101(1):201\u201311. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04357.x.","journal-title":"J Neurochem"},{"issue":"2","key":"709_CR226","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1600-0854.2008.00853.x","volume":"10","author":"T Ben Gedalya","year":"2009","unstructured":"Ben Gedalya T, Loeb V, Israeli E, Altschuler Y, Selkoe DJ, Sharon R. \u03b1-Synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling. Traffic. 2009;10(2):218\u201334. https:\/\/doi.org\/10.1111\/j.1600-0854.2008.00853.x.","journal-title":"Traffic"},{"issue":"20","key":"709_CR227","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1523\/jneurosci.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking \u03b1-synuclein. J Neurosci. 2002;22(20):8797\u2013807. https:\/\/doi.org\/10.1523\/jneurosci.22-20-08797.2002.","journal-title":"J Neurosci"},{"issue":"9","key":"709_CR228","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1523\/jneurosci.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy DD, Rueter SM, Trojanowski JQ, Lee VM-Y. Synucleins are developmentally expressed, and \u03b1-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci. 2000;20(9):3214\u201320. https:\/\/doi.org\/10.1523\/jneurosci.20-09-03214.2000.","journal-title":"J Neurosci"},{"issue":"1","key":"709_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0241-0","volume":"13","author":"K Yamada","year":"2018","unstructured":"Yamada K, Iwatsubo T. Extracellular \u03b1-synuclein levels are regulated by neuronal activity. Mol Neurodegener. 2018;13(1):1\u20138. https:\/\/doi.org\/10.1186\/s13024-018-0241-0.","journal-title":"Mol Neurodegener"},{"issue":"23","key":"709_CR230","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1073\/pnas.1903049116","volume":"116","author":"J Sun","year":"2019","unstructured":"Sun J, Wang L, Bao H, Premi S, Das U, Chapman ER, Roy S. Functional cooperation of \u03b1-synuclein and VAMP2 in synaptic vesicle recycling. Proc Natl Acad Sci. 2019;116(23):11113\u20135. https:\/\/doi.org\/10.1073\/pnas.1903049116.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"709_CR231","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.celrep.2016.12.023","volume":"18","author":"KJ Vargas","year":"2017","unstructured":"Vargas KJ, Schrod N, Davis T, Fernandez-Busnadiego R, Taguchi YV, Laugks U, Lucic V, Chandra SS. Synucleins have multiple effects on presynaptic architecture. Cell Rep. 2017;18(1):161\u201373. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.023.","journal-title":"Cell Rep"},{"issue":"1","key":"709_CR232","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Fari\u00f1as I, Choi-Lundberg D, Ho W-H, Castillo PE, Shinsky N, Verdugo JMG, Armanini M, Ryan A. Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25(1):239\u201352. https:\/\/doi.org\/10.1016\/s0896-6273(00)80886-7.","journal-title":"Neuron"},{"issue":"49","key":"709_CR233","doi-asserted-by":"publisher","first-page":"11165","DOI":"10.1523\/jneurosci.2559-04.2004","volume":"24","author":"L Yavich","year":"2004","unstructured":"Yavich L, Tanila H, Veps\u00e4l\u00e4inen S, J\u00e4k\u00e4l\u00e4 P. Role of \u03b1-synuclein in presynaptic dopamine recruitment. J Neurosci. 2004;24(49):11165\u201370. https:\/\/doi.org\/10.1523\/jneurosci.2559-04.2004.","journal-title":"J Neurosci"},{"issue":"24","key":"709_CR234","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1523\/jneurosci.1091-10.2010","volume":"30","author":"DA Scott","year":"2010","unstructured":"Scott DA, Tabarean I, Tang Y, Cartier A, Masliah E, Roy S. A pathologic cascade leading to synaptic dysfunction in \u03b1-synuclein-induced neurodegeneration. J Neurosci. 2010;30(24):8083\u201395. https:\/\/doi.org\/10.1523\/jneurosci.1091-10.2010.","journal-title":"J Neurosci"},{"issue":"1","key":"709_CR235","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA, Edwards RH. Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron. 2010;65(1):66\u201379. https:\/\/doi.org\/10.1016\/j.neuron.2009.12.023.","journal-title":"Neuron"},{"issue":"5","key":"709_CR236","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00401-012-0963-y","volume":"123","author":"MN Gaugler","year":"2012","unstructured":"Gaugler MN, Genc O, Bobela W, Mohanna S, Ardah MT, El-Agnaf OM, Cantoni M, Bensadoun J-C, Schneggenburger R, Knott GW. Nigrostriatal overabundance of \u03b1-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity. Acta Neuropathol. 2012;123(5):653\u201369. https:\/\/doi.org\/10.1007\/s00401-012-0963-y.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"709_CR237","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1073\/pnas.1200575109","volume":"109","author":"M Lundblad","year":"2012","unstructured":"Lundblad M, Decressac M, Mattsson B, Bj\u00f6rklund A. Impaired neurotransmission caused by overexpression of \u03b1-synuclein in nigral dopamine neurons. Proc Natl Acad Sci. 2012;109(9):3213\u20139. https:\/\/doi.org\/10.1073\/pnas.1200575109.","journal-title":"Proc Natl Acad Sci"},{"issue":"46","key":"709_CR238","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1523\/jneurosci.3821-06.2006","volume":"26","author":"KE Larsen","year":"2006","unstructured":"Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle M, Nemani V, Chaudhry FA, Edwards RH. \u03b1-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci. 2006;26(46):11915\u201322. https:\/\/doi.org\/10.1523\/jneurosci.3821-06.2006.","journal-title":"J Neurosci"},{"issue":"23","key":"709_CR239","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1073\/pnas.1903054116","volume":"116","author":"M Atias","year":"2019","unstructured":"Atias M, Tevet Y, Sun J, Stavsky A, Tal S, Kahn J, Roy S, Gitler D. Synapsins regulate \u03b1-synuclein functions. Proc Natl Acad Sci. 2019;116(23):11116\u20138. https:\/\/doi.org\/10.1073\/pnas.1903054116.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"709_CR240","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jmb.2004.02.014","volume":"337","author":"JE Payton","year":"2004","unstructured":"Payton JE, Perrin RJ, Woods WS, George JM. Structural determinants of PLD2 inhibition by \u03b1-synuclein. J Mol Biol. 2004;337(4):1001\u20139. https:\/\/doi.org\/10.1016\/j.jmb.2004.02.014.","journal-title":"J Mol Biol"},{"issue":"1\u20132","key":"709_CR241","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neulet.2005.01.034","volume":"380","author":"E Dalfo","year":"2005","unstructured":"Dalfo E, Ferrer I. \u03b1-Synuclein binding to rab3a in multiple system atrophy. Neurosci Lett. 2005;380(1\u20132):170\u20135. https:\/\/doi.org\/10.1016\/j.neulet.2005.01.034.","journal-title":"Neurosci Lett"},{"issue":"5999","key":"709_CR242","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, S\u00fcdhof TC. \u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329(5999):1663\u20137. https:\/\/doi.org\/10.1126\/science.1195227.","journal-title":"Science"},{"issue":"41","key":"709_CR243","doi-asserted-by":"publisher","first-page":"14966","DOI":"10.1073\/pnas.0406283101","volume":"101","author":"S Chandra","year":"2004","unstructured":"Chandra S, Fornai F, Kwon H-B, Yazdani U, Atasoy D, Liu X, Hammer RE, Battaglia G, German DC, Castillo PE. Double-knockout mice for \u03b1-and \u03b2-synucleins: effect on synaptic functions. Proc Natl Acad Sci. 2004;101(41):14966\u201371. https:\/\/doi.org\/10.1073\/pnas.0406283101.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"709_CR244","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra S, Gallardo G, Fern\u00e1ndez-Chac\u00f3n R, Schl\u00fcter OM, S\u00fcdhof TC. \u03b1-Synuclein cooperates with CSP\u03b1 in preventing neurodegeneration. Cell. 2005;123(3):383\u201396. https:\/\/doi.org\/10.1016\/j.cell.2005.09.028.","journal-title":"Cell"},{"issue":"43","key":"709_CR245","doi-asserted-by":"publisher","first-page":"13709","DOI":"10.1021\/bi961799n","volume":"35","author":"PH Weinreb","year":"1996","unstructured":"Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT. NACP, a protein implicated in Alzheimer\u2019s disease and learning, is natively unfolded. Biochemistry. 1996;35(43):13709\u201315. https:\/\/doi.org\/10.1021\/bi961799n.","journal-title":"Biochemistry"},{"issue":"7453","key":"709_CR246","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1038\/nature12125","volume":"498","author":"J Burr\u00e9","year":"2013","unstructured":"Burr\u00e9 J, Vivona S, Diao J, Sharma M, Brunger AT, S\u00fcdhof TC. Properties of native brain \u03b1-synuclein. Nature. 2013;498(7453):E4\u20136. https:\/\/doi.org\/10.1038\/nature12125.","journal-title":"Nature"},{"issue":"7588","key":"709_CR247","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature16531","volume":"530","author":"F-X Theillet","year":"2016","unstructured":"Theillet F-X, Binolfi A, Bekei B, Martorana A, Rose HM, Stuiver M, Verzini S, Lorenz D, Van Rossum M, Goldfarb D. Structural disorder of monomeric \u03b1-synuclein persists in mammalian cells. Nature. 2016;530(7588):45\u201350. https:\/\/doi.org\/10.1038\/nature16531.","journal-title":"Nature"},{"issue":"6","key":"709_CR248","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1021\/acs.jpclett.8b00092","volume":"9","author":"MA Fakhree","year":"2018","unstructured":"Fakhree MA, Nolten IS, Blum C, Claessens MM. Different conformational subensembles of the intrinsically disordered protein \u03b1-synuclein in cells. J Phys Chem Lett. 2018;9(6):1249\u201353. https:\/\/doi.org\/10.1021\/acs.jpclett.8b00092.","journal-title":"J Phys Chem Lett"},{"issue":"1","key":"709_CR249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0859-3","volume":"7","author":"NL Rey","year":"2019","unstructured":"Rey NL, Bousset L, George S, Madaj Z, Meyerdirk L, Schulz E, Steiner JA, Melki R, Brundin P. \u03b1-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb. Acta Neuropathol Commun. 2019;7(1):1\u201318. https:\/\/doi.org\/10.1186\/s40478-019-0859-3.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"709_CR250","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1021\/acs.jctc.8b00183","volume":"14","author":"IM Ilie","year":"2018","unstructured":"Ilie IM, Nayar D, Den Otter WK, Van Der Vegt NF, Briels WJ. Intrinsic conformational preferences and interactions in \u03b1-synuclein fibrils: insights from molecular dynamics simulations. J Chem Theory Comput. 2018;14(6):3298\u2013310. https:\/\/doi.org\/10.1021\/acs.jctc.8b00183.","journal-title":"J Chem Theory Comput"},{"issue":"11","key":"709_CR251","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1074\/jbc.c113.538249","volume":"289","author":"N Gould","year":"2014","unstructured":"Gould N, Mor DE, Lightfoot R, Malkus K, Giasson B, Ischiropoulos H. Evidence of native \u03b1-synuclein conformers in the human brain. J Biol Chem. 2014;289(11):7929\u201334. https:\/\/doi.org\/10.1074\/jbc.c113.538249.","journal-title":"J Biol Chem"},{"issue":"11","key":"709_CR252","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease. Nat Med. 1998;4(11):1318\u201320. https:\/\/doi.org\/10.1038\/3311.","journal-title":"Nat Med"},{"issue":"19","key":"709_CR253","doi-asserted-by":"publisher","first-page":"15345","DOI":"10.1074\/jbc.m111.318949","volume":"287","author":"B Fauvet","year":"2012","unstructured":"Fauvet B, Mbefo MK, Fares M-B, Desobry C, Michael S, Ardah MT, Tsika E, Coune P, Prudent M, Lion N. \u03b1-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem. 2012;287(19):15345\u201364. https:\/\/doi.org\/10.1074\/jbc.m111.318949.","journal-title":"J Biol Chem"},{"issue":"47","key":"709_CR254","doi-asserted-by":"publisher","first-page":"44284","DOI":"10.1074\/jbc.m105343200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fibrillation of human \u03b1-synuclein a possible molecular link between parkinson\u2019s disease and heavy metal exposure. J Biol Chem. 2001;276(47):44284\u201396. https:\/\/doi.org\/10.1074\/jbc.m105343200.","journal-title":"J Biol Chem"},{"issue":"14","key":"709_CR255","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1074\/jbc.m010907200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL. Evidence for a partially folded intermediate in \u03b1-synuclein fibril formation. J Biol Chem. 2001;276(14):10737\u201344. https:\/\/doi.org\/10.1074\/jbc.m010907200.","journal-title":"J Biol Chem"},{"issue":"7362","key":"709_CR256","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ. \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477(7362):107\u201310. https:\/\/doi.org\/10.1038\/nature10324.","journal-title":"Nature"},{"issue":"43","key":"709_CR257","doi-asserted-by":"publisher","first-page":"17797","DOI":"10.1073\/pnas.1113260108","volume":"108","author":"W Wang","year":"2011","unstructured":"Wang W, Perovic I, Chittuluru J, Kaganovich A, Nguyen LT, Liao J, Auclair JR, Johnson D, Landeru A, Simorellis AK. A soluble \u03b1-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci. 2011;108(43):17797\u2013802. https:\/\/doi.org\/10.1073\/pnas.1113260108.","journal-title":"Proc Natl Acad Sci"},{"issue":"31","key":"709_CR258","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1073\/pnas.1505953112","volume":"112","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Newman AJ, von Saucken VE, Bartels T, Selkoe D. KTKEGV repeat motifs are key mediators of normal \u03b1-synuclein tetramerization: their mutation causes excess monomers and neurotoxicity. Proc Natl Acad Sci. 2015;112(31):9596\u2013601. https:\/\/doi.org\/10.1073\/pnas.1505953112.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"709_CR259","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1021\/ja310518p","volume":"135","author":"T Gurry","year":"2013","unstructured":"Gurry T, Ullman O, Fisher CK, Perovic I, Pochapsky T, Stultz CM. The dynamic structure of \u03b1-synuclein multimers. J Am Chem Soc. 2013;135(10):3865\u201372. https:\/\/doi.org\/10.1021\/ja310518p.","journal-title":"J Am Chem Soc"},{"key":"709_CR260","doi-asserted-by":"publisher","DOI":"10.1042\/bst20120096","author":"A Binolfi","year":"2012","unstructured":"Binolfi A, Theillet F-X, Selenko P. Bacterial in-cell NMR of human \u03b1-synuclein: a disordered monomer by nature? Biochem Soc Trans. 2012. https:\/\/doi.org\/10.1042\/bst20120096.","journal-title":"Biochem Soc Trans"},{"issue":"34","key":"709_CR261","doi-asserted-by":"publisher","first-page":"28243","DOI":"10.1074\/jbc.m112.383711","volume":"287","author":"B Fauvet","year":"2012","unstructured":"Fauvet B, Fares M-B, Samuel F, Dikiy I, Tandon A, Eliezer D, Lashuel HA. Characterization of semisynthetic and naturally n\u03b1-acetylated \u03b1-synuclein in vitro and in intact cells implications for aggregation and cellular properties of \u03b1-synuclein. J Biol Chem. 2012;287(34):28243\u201362. https:\/\/doi.org\/10.1074\/jbc.m112.383711.","journal-title":"J Biol Chem"},{"issue":"1","key":"709_CR262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-23718-3","volume":"8","author":"S Ghosh","year":"2018","unstructured":"Ghosh S, Kundu A, Chattopadhyay K. Small molecules attenuate the interplay between conformational fluctuations, early oligomerization and amyloidosis of alpha synuclein. Sci Rep. 2018;8(1):1\u201316. https:\/\/doi.org\/10.1038\/s41598-018-23718-3.","journal-title":"Sci Rep"},{"issue":"25","key":"709_CR263","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","volume":"58","author":"AK Dasari","year":"2019","unstructured":"Dasari AK, Kayed R, Wi S, Lim KH. Tau interacts with the C-terminal region of \u03b1-synuclein, promoting formation of toxic aggregates with distinct molecular conformations. Biochemistry. 2019;58(25):2814\u201321. https:\/\/doi.org\/10.1021\/acs.biochem.9b00215.","journal-title":"Biochemistry"},{"issue":"32","key":"709_CR264","doi-asserted-by":"publisher","first-page":"18977","DOI":"10.1073\/pnas.2006291117","volume":"117","author":"U Kaur","year":"2020","unstructured":"Kaur U, Lee JC. Unroofing site-specific \u03b1-synuclein\u2013lipid interactions at the plasma membrane. Proc Natl Acad Sci. 2020;117(32):18977\u201383. https:\/\/doi.org\/10.1073\/pnas.2006291117.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"709_CR265","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuron.2017.12.012","volume":"97","author":"F Zunke","year":"2018","unstructured":"Zunke F, Moise AC, Belur NR, Gelyana E, Stojkovska I, Dzaferbegovic H, Toker NJ, Jeon S, Fredriksen K, Mazzulli JR. Reversible conformational conversion of \u03b1-synuclein into toxic assemblies by glucosylceramide. Neuron. 2018;97(1):92-107.e110. https:\/\/doi.org\/10.1016\/j.neuron.2017.12.012.","journal-title":"Neuron"},{"issue":"2","key":"709_CR266","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C. Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol. 2017;74(2):163\u201372. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4547.","journal-title":"JAMA Neurol"},{"issue":"10","key":"709_CR267","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1523\/jneurosci.5368-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, Lee MK. Accumulation of toxic \u03b1-synuclein oligomer within endoplasmic reticulum occurs in \u03b1-synucleinopathy in vivo. J Neurosci. 2012;32(10):3301\u20135. https:\/\/doi.org\/10.1523\/jneurosci.5368-11.2012.","journal-title":"J Neurosci"},{"issue":"1","key":"709_CR268","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12035-018-1082-0","volume":"56","author":"A Wilkaniec","year":"2019","unstructured":"Wilkaniec A, Lenkiewicz AM, Czapski GA, J\u0119\u015bko HM, Hilgier W, Brodzik R, G\u0105ssowska-Dobrowolska M, Culmsee C, Adamczyk A. Extracellular alpha-synuclein oligomers induce parkin s-nitrosylation: relevance to sporadic Parkinson\u2019s disease etiopathology. Mol Neurobiol. 2019;56(1):125\u201340. https:\/\/doi.org\/10.1007\/s12035-018-1082-0.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"709_CR269","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001867","volume":"3","author":"TF Outeiro","year":"2008","unstructured":"Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ. Formation of toxic oligomeric \u03b1-synuclein species in living cells. PLoS ONE. 2008;3(4): e1867. https:\/\/doi.org\/10.1371\/journal.pone.0001867.","journal-title":"PLoS ONE"},{"issue":"3","key":"709_CR270","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt255","volume":"6","author":"O Hansson","year":"2014","unstructured":"Hansson O, Hall S, \u00d6hrfelt A, Zetterberg H, Blennow K, Minthon L, N\u00e4gga K, Londos E, Varghese S, Majbour NK. Levels of cerebrospinal fluid \u03b1-synuclein oligomers are increased in Parkinson\u2019s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2014;6(3):1\u20136. https:\/\/doi.org\/10.1186\/alzrt255.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"4","key":"709_CR271","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/brain\/awn349","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou KE, Kragh CL, Mann DM, Salem SA, Al-Shami R, Allsop D, Hassan AH, Jensen PH, El-Agnaf OM. Detection of elevated levels of soluble \u03b1-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain. 2009;132(4):1093\u2013101. https:\/\/doi.org\/10.1093\/brain\/awn349.","journal-title":"Brain"},{"issue":"21","key":"709_CR272","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1073\/pnas.1315346111","volume":"111","author":"AK Buell","year":"2014","unstructured":"Buell AK, Galvagnion C, Gaspar R, Sparr E, Vendruscolo M, Knowles TP, Linse S, Dobson CM. Solution conditions determine the relative importance of nucleation and growth processes in \u03b1-synuclein aggregation. Proc Natl Acad Sci. 2014;111(21):7671\u20136. https:\/\/doi.org\/10.1073\/pnas.1315346111.","journal-title":"Proc Natl Acad Sci"},{"issue":"14","key":"709_CR273","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1073\/pnas.0809232106","volume":"106","author":"ACM Ferreon","year":"2009","unstructured":"Ferreon ACM, Gambin Y, Lemke EA, Deniz AA. Interplay of \u03b1-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc Natl Acad Sci. 2009;106(14):5645\u201350. https:\/\/doi.org\/10.1073\/pnas.0809232106.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"709_CR274","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1523\/jneurosci.3784-11.2012","volume":"32","author":"A Oueslati","year":"2012","unstructured":"Oueslati A, Paleologou KE, Schneider BL, Aebischer P, Lashuel HA. Mimicking phosphorylation at serine 87 inhibits the aggregation of human \u03b1-synuclein and protects against its toxicity in a rat model of Parkinson\u2019s disease. J Neurosci. 2012;32(5):1536\u201344. https:\/\/doi.org\/10.1523\/jneurosci.3784-11.2012.","journal-title":"J Neurosci"},{"issue":"24","key":"709_CR275","doi-asserted-by":"publisher","first-page":"18344","DOI":"10.1074\/jbc.m000206200","volume":"275","author":"JM Souza","year":"2000","unstructured":"Souza JM, Giasson BI, Chen Q, Lee VM-Y, Ischiropoulos H. Dityrosine cross-linking promotes formation of stable \u03b1-synuclein polymers implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem. 2000;275(24):18344\u20139. https:\/\/doi.org\/10.1074\/jbc.m000206200.","journal-title":"J Biol Chem"},{"issue":"4","key":"709_CR276","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","volume":"10","author":"M Hashimoto","year":"1999","unstructured":"Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E. Oxidative stress induces amyloid-like aggregate formation of NACP\/\u03b1-synuclein in vitro. NeuroReport. 1999;10(4):717\u201321. https:\/\/doi.org\/10.1097\/00001756-199903170-00011.","journal-title":"NeuroReport"},{"issue":"9","key":"709_CR277","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1523\/jneurosci.5922-09.2010","volume":"30","author":"KE Paleologou","year":"2010","unstructured":"Paleologou KE, Oueslati A, Shakked G, Rospigliosi CC, Kim H-Y, Lamberto GR, Fernandez CO, Schmid A, Chegini F, Gai WP. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits \u03b1-synuclein oligomerization, and influences synuclein-membrane interactions. J Neurosci. 2010;30(9):3184\u201398. https:\/\/doi.org\/10.1523\/jneurosci.5922-09.2010.","journal-title":"J Neurosci"},{"issue":"3","key":"709_CR278","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nchembio.1750","volume":"11","author":"C Galvagnion","year":"2015","unstructured":"Galvagnion C, Buell AK, Meisl G, Michaels TC, Vendruscolo M, Knowles TP, Dobson CM. Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation. Nat Chem Biol. 2015;11(3):229\u201334. https:\/\/doi.org\/10.1038\/nchembio.1750.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"709_CR279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-73207-9","volume":"10","author":"R Moons","year":"2020","unstructured":"Moons R, Konijnenberg A, Mensch C, Van Elzen R, Johannessen C, Maudsley S, Lambeir A-M, Sobott F. Metal ions shape \u03b1-synuclein. Sci Rep. 2020;10(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-020-73207-9.","journal-title":"Sci Rep"},{"issue":"5545","key":"709_CR280","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway KA, Rochet J-C, Bieganski RM, Lansbury PT. Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct. Science. 2001;294(5545):1346\u20139. https:\/\/doi.org\/10.1126\/science.1063522.","journal-title":"Science"},{"issue":"5","key":"709_CR281","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SI, Deas E, Abramov AY, Chen AY, Orte A, Sandal M, Clarke RW, Dunne P, Aprile FA. Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell. 2012;149(5):1048\u201359. https:\/\/doi.org\/10.1016\/j.cell.2012.03.037.","journal-title":"Cell"},{"issue":"9","key":"709_CR282","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1021\/ar050073t","volume":"39","author":"AL Fink","year":"2006","unstructured":"Fink AL. The aggregation and fibrillation of \u03b1-synuclein. Acc Chem Res. 2006;39(9):628\u201334. https:\/\/doi.org\/10.1021\/ar050073t.","journal-title":"Acc Chem Res"},{"issue":"2","key":"709_CR283","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM, Mollenhauer B, Schneider A. Induction of \u03b1-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies. Brain. 2016;139(2):481\u201394. https:\/\/doi.org\/10.1093\/brain\/awv346.","journal-title":"Brain"},{"issue":"1","key":"709_CR284","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-017-0445-5","volume":"5","author":"J Ngolab","year":"2017","unstructured":"Ngolab J, Trinh I, Rockenstein E, Mante M, Florio J, Trejo M, Masliah D, Adame A, Masliah E, Rissman RA. Brain-derived exosomes from dementia with Lewy bodies propagate \u03b1-synuclein pathology. Acta Neuropathol Commun. 2017;5(1):1\u201310. https:\/\/doi.org\/10.1186\/s40478-017-0445-5.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"709_CR285","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1007\/s12035-017-0624-1","volume":"55","author":"K Sano","year":"2018","unstructured":"Sano K, Atarashi R, Satoh K, Ishibashi D, Nakagaki T, Iwasaki Y, Yoshida M, Murayama S, Mishima K, Nishida N. Prion-like seeding of misfolded \u03b1-synuclein in the brains of dementia with Lewy body patients in RT-QUIC. Mol Neurobiol. 2018;55(5):3916\u201330. https:\/\/doi.org\/10.1007\/s12035-017-0624-1.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"709_CR286","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, Lansbury PT. Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci. 2000;97(2):571\u20136. https:\/\/doi.org\/10.1073\/pnas.97.2.571.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"709_CR287","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, Hetzer C, Loher T, Vilar M, Campioni S. In vivo demonstration that \u03b1-synuclein oligomers are toxic. Proc Natl Acad Sci. 2011;108(10):4194\u20139. https:\/\/doi.org\/10.1073\/pnas.1100976108.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"709_CR288","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/brain\/awu057","volume":"137","author":"E Rockenstein","year":"2014","unstructured":"Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Trejo-Morales M, Gerez J, Picotti P. Accumulation of oligomer-prone \u03b1-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain. 2014;137(5):1496\u2013513. https:\/\/doi.org\/10.1093\/brain\/awu057.","journal-title":"Brain"},{"issue":"3","key":"709_CR289","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1385\/jmn:24:3:343","volume":"24","author":"M Hashimoto","year":"2004","unstructured":"Hashimoto M, Kawahara K, Bar-On P, Rockenstein E, Crews L, Masliah E. The role of \u03b1-synuclein assembly and metabolism in the pathogenesis of Lewy body disease. J Mol Neurosci. 2004;24(3):343\u201352. https:\/\/doi.org\/10.1385\/jmn:24:3:343.","journal-title":"J Mol Neurosci"},{"issue":"34","key":"709_CR290","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/jneurosci.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M. Different species of \u03b1-synuclein oligomers induce calcium influx and seeding. J Neurosci. 2007;27(34):9220\u201332. https:\/\/doi.org\/10.1523\/jneurosci.2617-07.2007.","journal-title":"J Neurosci"},{"issue":"2","key":"709_CR291","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/s0002-9440(10)64553-1","volume":"157","author":"LJ Hsu","year":"2000","unstructured":"Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E. \u03b1-Synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol. 2000;157(2):401\u201310. https:\/\/doi.org\/10.1016\/s0002-9440(10)64553-1.","journal-title":"Am J Pathol"},{"issue":"4","key":"709_CR292","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3233\/jad-2004-6412","volume":"6","author":"MA Alim","year":"2004","unstructured":"Alim MA, Ma Q-L, Takeda K, Aizawa T, Matsubara M, Nakamura M, Asada A, Saito T, Xkaji M, Yoshii M. Demonstration of a role for \u03b1-synuclein as a functional microtubule-associated protein. J Alzheimer\u2019s Dis. 2004;6(4):435\u201342. https:\/\/doi.org\/10.3233\/jad-2004-6412.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"709_CR293","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1073\/pnas.0711053105","volume":"105","author":"OS Gorbatyuk","year":"2008","unstructured":"Gorbatyuk OS, Li S, Sullivan LF, Chen W, Kondrikova G, Manfredsson FP, Mandel RJ, Muzyczka N. The phosphorylation state of Ser-129 in human \u03b1-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc Natl Acad Sci. 2008;105(2):763\u20138. https:\/\/doi.org\/10.1073\/pnas.0711053105.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"709_CR294","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/hmg\/ddn417","volume":"18","author":"S Azeredo da Silveira","year":"2009","unstructured":"Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C, Sage D, Abbas-Terki T, Iwatsubo T, Unser M, Aebischer P. Phosphorylation does not prompt, nor prevent, the formation of \u03b1-synuclein toxic species in a rat model of Parkinson\u2019s disease. Hum Mol Genet. 2009;18(5):872\u201387. https:\/\/doi.org\/10.1093\/hmg\/ddn417.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"709_CR295","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00401-011-0926-8","volume":"123","author":"G Taschenberger","year":"2012","unstructured":"Taschenberger G, Garrido M, Tereshchenko Y, B\u00e4hr M, Zweckstetter M, K\u00fcgler S. Aggregation of \u03b1Synuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. Acta Neuropathol. 2012;123(5):671\u201383. https:\/\/doi.org\/10.1007\/s00401-011-0926-8.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"709_CR296","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1016\/j.bpj.2012.04.050","volume":"102","author":"L Pieri","year":"2012","unstructured":"Pieri L, Madiona K, Bousset L, Melki R. Fibrillar \u03b1-synuclein and huntingtin exon 1 assemblies are toxic to the cells. Biophys J. 2012;102(12):2894\u2013905. https:\/\/doi.org\/10.1016\/j.bpj.2012.04.050.","journal-title":"Biophys J"},{"issue":"7556","key":"709_CR297","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V. \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015;522(7556):340\u20134. https:\/\/doi.org\/10.1038\/nature14547.","journal-title":"Nature"},{"issue":"4","key":"709_CR298","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00401-021-02288-1","volume":"141","author":"A Sokratian","year":"2021","unstructured":"Sokratian A, Ziaee J, Kelly K, Chang A, Bryant N, Wang S, Xu E, Li JY, Wang S-H, Ervin J. Heterogeneity in \u03b1-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia. Acta Neuropathol. 2021;141(4):547\u201364. https:\/\/doi.org\/10.1007\/s00401-021-02288-1.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"709_CR299","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","volume":"139","author":"A Van der Perren","year":"2020","unstructured":"Van der Perren A, Gelders G, Fenyi A, Bousset L, Brito F, Peelaerts W, Van den Haute C, Gentleman S, Melki R, Baekelandt V. The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathol. 2020;139(6):977\u20131000. https:\/\/doi.org\/10.1007\/s00401-020-02157-3.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"709_CR300","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li B, Ge P, Murray KA, Sheth P, Zhang M, Nair G, Sawaya MR, Shin WS, Boyer DR, Ye S. Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel. Nat Commun. 2018;9(1):1\u201310. https:\/\/doi.org\/10.1038\/s41467-018-05971-2.","journal-title":"Nat Commun"},{"key":"709_CR301","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36402","volume":"7","author":"R Guerrero-Ferreira","year":"2018","unstructured":"Guerrero-Ferreira R, Taylor NM, Mona D, Ringler P, Lauer ME, Riek R, Britschgi M, Stahlberg H. Cryo-EM structure of alpha-synuclein fibrils. Elife. 2018;7: e36402. https:\/\/doi.org\/10.7554\/eLife.36402.","journal-title":"Elife"},{"issue":"5","key":"709_CR302","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1176\/appi.ajp.161.5.843","volume":"161","author":"CG Ballard","year":"2004","unstructured":"Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with Lewy bodies. Am J Psychiatry. 2004;161(5):843\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.161.5.843.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"709_CR303","first-page":"267","volume":"148","author":"C Bergeron","year":"1996","unstructured":"Bergeron C, Petrunka C, Weyer L, Pollanen MS. Altered neurofilament expression does not contribute to Lewy body formation. Am J Pathol. 1996;148(1):267.","journal-title":"Am J Pathol"},{"issue":"1\u20132","key":"709_CR304","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0022-510x(03)00037-6","volume":"211","author":"O Katsuse","year":"2003","unstructured":"Katsuse O, Iseki E, Marui W, Kosaka K. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci. 2003;211(1\u20132):29\u201335. https:\/\/doi.org\/10.1016\/s0022-510x(03)00037-6.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"709_CR305","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/s0006-8993(97)00874-3","volume":"775","author":"MM Tompkins","year":"1997","unstructured":"Tompkins MM, Hill WD. Contribution of somal Lewy bodies to neuronal death. Brain Res. 1997;775(1\u20132):24\u20139. https:\/\/doi.org\/10.1016\/s0006-8993(97)00874-3.","journal-title":"Brain Res"},{"issue":"7706","key":"709_CR306","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC. Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature. 2018;557(7706):558\u201363. https:\/\/doi.org\/10.1038\/s41586-018-0104-4.","journal-title":"Nature"},{"issue":"5","key":"709_CR307","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1471-4159.2010.06695.x","volume":"113","author":"A Jang","year":"2010","unstructured":"Jang A, Lee HJ, Suk JE, Jung JW, Kim KP, Lee SJ. Non-classical exocytosis of \u03b1-synuclein is sensitive to folding states and promoted under stress conditions. J Neurochem. 2010;113(5):1263\u201374. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06695.x.","journal-title":"J Neurochem"},{"issue":"1","key":"709_CR308","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1096\/fj.10-164624","volume":"25","author":"KM Danzer","year":"2011","unstructured":"Danzer KM, Ruf WP, Putcha P, Joyner D, Hashimoto T, Glabe C, Hyman BT, McLean PJ. Heat-shock protein 70 modulates toxic extracellular \u03b1-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 2011;25(1):326\u201336. https:\/\/doi.org\/10.1096\/fj.10-164624.","journal-title":"FASEB J"},{"issue":"3","key":"709_CR309","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis. 2011;42(3):360\u20137. https:\/\/doi.org\/10.1016\/j.nbd.2011.01.029.","journal-title":"Neurobiol Dis"},{"issue":"19","key":"709_CR310","doi-asserted-by":"publisher","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","volume":"110","author":"M Decressac","year":"2013","unstructured":"Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Bj\u00f6rklund A. TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity. Proc Natl Acad Sci. 2013;110(19):E1817\u201326. https:\/\/doi.org\/10.1073\/pnas.1305623110.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"709_CR311","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/15548627.2019.1603545","volume":"16","author":"PW-L Ho","year":"2020","unstructured":"Ho PW-L, Leung C-T, Liu H, Pang SY-Y, Lam CS-C, Xian J, Li L, Kung MH-W, Ramsden DB, Ho S-L. Age-dependent accumulation of oligomeric SNCA\/\u03b1-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Autophagy. 2020;16(2):347\u201370. https:\/\/doi.org\/10.1080\/15548627.2019.1603545.","journal-title":"Autophagy"},{"issue":"1","key":"709_CR312","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","volume":"14","author":"G Minakaki","year":"2018","unstructured":"Minakaki G, Menges S, Kittel A, Emmanouilidou E, Schaeffner I, Barkovits K, Bergmann A, Rockenstein E, Adame A, Marxreiter F. Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018;14(1):98\u2013119. https:\/\/doi.org\/10.1080\/15548627.2017.1395992.","journal-title":"Autophagy"},{"issue":"9","key":"709_CR313","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","volume":"40","author":"H-J Lee","year":"2008","unstructured":"Lee H-J, Suk J-E, Bae E-J, Lee J-H, Paik SR, Lee S-J. Assembly-dependent endocytosis and clearance of extracellular a-synuclein. Int J Biochem Cell Biol. 2008;40(9):1835\u201349. https:\/\/doi.org\/10.1016\/j.biocel.2008.01.017.","journal-title":"Int J Biochem Cell Biol"},{"issue":"29","key":"709_CR314","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1523\/jneurosci.3085-18.2019","volume":"39","author":"T Tsunemi","year":"2019","unstructured":"Tsunemi T, Perez-Rosello T, Ishiguro Y, Yoroisaka A, Jeon S, Hamada K, Rammonhan M, Wong YC, Xie Z, Akamatsu W. Increased lysosomal exocytosis induced by lysosomal Ca2+ channel agonists protects human dopaminergic neurons from \u03b1-synuclein toxicity. J Neurosci. 2019;39(29):5760\u201372. https:\/\/doi.org\/10.1523\/jneurosci.3085-18.2019.","journal-title":"J Neurosci"},{"issue":"25","key":"709_CR315","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"H-J Lee","year":"2005","unstructured":"Lee H-J, Patel S, Lee S-J. Intravesicular localization and exocytosis of \u03b1-synuclein and its aggregates. J Neurosci. 2005;25(25):6016\u201324. https:\/\/doi.org\/10.1523\/JNEUROSCI.0692-05.2005.","journal-title":"J Neurosci"},{"issue":"20","key":"709_CR316","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/jneurosci.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K. Cell-produced \u03b1-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci. 2010;30(20):6838\u201351. https:\/\/doi.org\/10.1523\/jneurosci.5699-09.2010.","journal-title":"J Neurosci"},{"issue":"5","key":"709_CR317","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M, Wang J, Zhao Y, Feng Y, Han S, Dong Q, Cui M, Tieu K. Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease. Brain. 2020;143(5):1476\u201397. https:\/\/doi.org\/10.1093\/brain\/awaa090.","journal-title":"Brain"},{"issue":"3","key":"709_CR318","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1404-9","volume":"10","author":"Y Xia","year":"2019","unstructured":"Xia Y, Zhang G, Han C, Ma K, Guo X, Wan F, Kou L, Yin S, Liu L, Huang J. Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis. 2019;10(3):1\u201315. https:\/\/doi.org\/10.1038\/s41419-019-1404-9.","journal-title":"Cell Death Dis"},{"issue":"6","key":"709_CR319","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1742-4658.2012.08489.x","volume":"279","author":"IF Tsigelny","year":"2012","unstructured":"Tsigelny IF, Sharikov Y, Wrasidlo W, Gonzalez T, Desplats PA, Crews L, Spencer B, Masliah E. Role of \u03b1-synuclein penetration into the membrane in the mechanisms of oligomer pore formation. FEBS J. 2012;279(6):1000\u201313. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08489.x.","journal-title":"FEBS J"},{"issue":"50","key":"709_CR320","doi-asserted-by":"publisher","first-page":"19666","DOI":"10.1073\/pnas.0807826105","volume":"105","author":"CC Jao","year":"2008","unstructured":"Jao CC, Hegde BG, Chen J, Haworth IS, Langen R. Structure of membrane-bound \u03b1-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci. 2008;105(50):19666\u201371. https:\/\/doi.org\/10.1073\/pnas.0807826105.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"709_CR321","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039465","volume":"7","author":"E Angot","year":"2012","unstructured":"Angot E, Steiner JA, Tom\u00e9 CML, Ekstr\u00f6m P, Mattsson B, Bj\u00f6rklund A, Brundin P. Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. PLoS ONE. 2012;7(6): e39465. https:\/\/doi.org\/10.1371\/journal.pone.0039465.","journal-title":"PLoS ONE"},{"key":"709_CR322","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2017.09.016","volume":"61","author":"S Zhang","year":"2018","unstructured":"Zhang S, Eitan E, Wu T-Y, Mattson MP. Intercellular transfer of pathogenic \u03b1-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal. Neurobiol Aging. 2018;61:52\u201365. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.09.016.","journal-title":"Neurobiol Aging"},{"issue":"31","key":"709_CR323","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee H-J, Bae E-J, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee S-J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of \u03b1-synuclein. Proc Natl Acad Sci. 2009;106(31):13010\u20135. https:\/\/doi.org\/10.1073\/pnas.0903691106.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"709_CR324","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM-Y. Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. 2011;72(1):57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033.","journal-title":"Neuron"},{"issue":"12","key":"709_CR325","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.m109.081125","volume":"285","author":"H-J Lee","year":"2010","unstructured":"Lee H-J, Suk J-E, Patrick C, Bae E-J, Cho J-H, Rho S, Hwang D, Masliah E, Lee S-J. Direct transfer of \u03b1-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 2010;285(12):9262\u201372. https:\/\/doi.org\/10.1074\/jbc.m109.081125.","journal-title":"J Biol Chem"},{"issue":"6","key":"709_CR326","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/brain\/awz104","volume":"142","author":"CW Olanow","year":"2019","unstructured":"Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH. Temporal evolution of microglia and \u03b1-synuclein accumulation following foetal grafting in Parkinson\u2019s disease. Brain. 2019;142(6):1690\u2013700. https:\/\/doi.org\/10.1093\/brain\/awz104.","journal-title":"Brain"},{"issue":"26","key":"709_CR327","doi-asserted-by":"publisher","first-page":"15209","DOI":"10.1073\/pnas.2001305117","volume":"117","author":"DB Hoban","year":"2020","unstructured":"Hoban DB, Shrigley S, Mattsson B, Breger LS, Jarl U, Cardoso T, Wahlestedt JN, Luk KC, Bj\u00f6rklund A, Parmar M. Impact of \u03b1-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized \u03b1-synuclein rat model of PD. Proc Natl Acad Sci. 2020;117(26):15209\u201320. https:\/\/doi.org\/10.1073\/pnas.2001305117.","journal-title":"Proc Natl Acad Sci"},{"issue":"16","key":"709_CR328","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1523\/JNEUROSCI.0066-08.2008","volume":"28","author":"L Crews","year":"2008","unstructured":"Crews L, Mizuno H, Desplats P, Rockenstein E, Adame A, Patrick C, Winner B, Winkler J, Masliah E. \u03b1-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice. J Neurosci. 2008;28(16):4250\u201360. https:\/\/doi.org\/10.1523\/JNEUROSCI.0066-08.2008.","journal-title":"J Neurosci"},{"issue":"5","key":"709_CR329","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3727\/000000005783983089","volume":"14","author":"J Karlsson","year":"2005","unstructured":"Karlsson J, Peters\u00e9n \u00c5, Gid\u00f6 G, Wieloch T, Brundin P. Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient. Cell Transplant. 2005;14(5):301\u20139. https:\/\/doi.org\/10.3727\/000000005783983089.","journal-title":"Cell Transplant"},{"issue":"8","key":"709_CR330","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1097\/00001756-200006050-00014","volume":"11","author":"J Karlsson","year":"2000","unstructured":"Karlsson J, Emg\u00e5rd M, Gid\u00f6 G, Wieloch T, Brundin P. Increased survival of embryonic nigral neurons when grafted to hypothermic rats. NeuroReport. 2000;11(8):1665\u20138. https:\/\/doi.org\/10.1097\/00001756-200006050-00014.","journal-title":"NeuroReport"},{"issue":"2","key":"709_CR331","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0006-8993(94)91328-5","volume":"647","author":"EM Frodl","year":"1994","unstructured":"Frodl EM, Duan W-M, Kupsch A, Brundin P. Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 1994;647(2):286\u201398. https:\/\/doi.org\/10.1016\/0006-8993(94)91328-5.","journal-title":"Brain Res"},{"key":"709_CR332","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.870130303","volume":"13","author":"JH Kordower","year":"1998","unstructured":"Kordower JH, Freeman TB, Olanow CW. Neuropathology of fetal nigral grafts in patients with Parkinson\u2019s disease. Mov Disord. 1998;13:88\u201395.","journal-title":"Mov Disord"},{"issue":"5","key":"709_CR333","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, R\u00fcb U, Gai W, Del Tredici K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. 2003;110(5):517\u201336. https:\/\/doi.org\/10.1007\/s00702-002-0808-2.","journal-title":"J Neural Transm"},{"issue":"4","key":"709_CR334","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","volume":"126","author":"KA Jellinger","year":"2019","unstructured":"Jellinger KA. Is Braak staging valid for all types of Parkinson\u2019s disease? J Neural Transm. 2019;126(4):423\u201331. https:\/\/doi.org\/10.1007\/s00702-018-1898-9.","journal-title":"J Neural Transm"},{"issue":"10","key":"709_CR335","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jnen\/nlz080","volume":"78","author":"CH Adler","year":"2019","unstructured":"Adler CH, Beach TG, Zhang N, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Sabbagh MN, Serrano GE, Sue LI. Unified staging system for Lewy body disorders: clinicopathologic correlations and comparison to Braak staging. J Neuropathol Exp Neurol. 2019;78(10):891\u20139. https:\/\/doi.org\/10.1093\/jnen\/nlz080.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"709_CR336","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, White CL, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J. Olfactory bulb \u03b1-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol. 2009;117(2):169\u201374. https:\/\/doi.org\/10.1007\/s00401-008-0450-7.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"709_CR337","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1749-6632.2003.tb07070.x","volume":"985","author":"JL Price","year":"2003","unstructured":"Price JL. Comparative aspects of amygdala connectivity. Ann N Y Acad Sci. 2003;985(1):50\u20138. https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb07070.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"709_CR338","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1152\/physrev.00002.2003","volume":"83","author":"P Sah","year":"2003","unstructured":"Sah P, Faber EL, Lopez de Armentia M, Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev. 2003;83(3):803\u201334. https:\/\/doi.org\/10.1152\/physrev.00002.2003.","journal-title":"Physiol Rev"},{"issue":"5","key":"709_CR339","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J. Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol. 2015;129(5):729\u201348. https:\/\/doi.org\/10.1007\/s00401-015-1406-3.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"709_CR340","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, Lee VM-Y, Brundin P. Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J Exp Med. 2016;213(9):1759\u201378. https:\/\/doi.org\/10.1084\/jem.20160368.","journal-title":"J Exp Med"},{"issue":"1","key":"709_CR341","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","volume":"135","author":"NL Rey","year":"2018","unstructured":"Rey NL, George S, Steiner JA, Madaj Z, Luk KC, Trojanowski JQ, Lee VMY, Brundin P. Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol. 2018;135(1):65\u201383. https:\/\/doi.org\/10.1007\/s00401-017-1792-9.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"709_CR342","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M. Prion-like spreading of pathological \u03b1-synuclein in brain. Brain. 2013;136(4):1128\u201338. https:\/\/doi.org\/10.1093\/brain\/awt037.","journal-title":"Brain"},{"issue":"28","key":"709_CR343","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.1523\/jneurosci.4787-13.2014","volume":"34","author":"KJ Vargas","year":"2014","unstructured":"Vargas KJ, Makani S, Davis T, Westphal CH, Castillo PE, Chandra SS. Synucleins regulate the kinetics of synaptic vesicle endocytosis. J Neurosci. 2014;34(28):9364\u201376. https:\/\/doi.org\/10.1523\/jneurosci.4787-13.2014.","journal-title":"J Neurosci"},{"key":"709_CR344","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fnins.2017.00172","volume":"11","author":"M Delenclos","year":"2017","unstructured":"Delenclos M, Trendafilova T, Mahesh D, Baine AM, Moussaud S, Yan IK, Patel T, McLean PJ. Investigation of endocytic pathways for the internalization of exosome-associated oligomeric alpha-synuclein. Front Neurosci. 2017;11:172. https:\/\/doi.org\/10.3389\/fnins.2017.00172.","journal-title":"Front Neurosci"},{"issue":"1","key":"709_CR345","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-04422-2","volume":"9","author":"MH Ludtmann","year":"2018","unstructured":"Ludtmann MH, Angelova PR, Horrocks MH, Choi ML, Rodrigues M, Baev AY, Berezhnov AV, Yao Z, Little D, Banushi B. \u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat Commun. 2018;9(1):1\u201316. https:\/\/doi.org\/10.1038\/s41467-018-04422-2.","journal-title":"Nat Commun"},{"issue":"34","key":"709_CR346","doi-asserted-by":"publisher","first-page":"11750","DOI":"10.1523\/jneurosci.0234-12.2012","volume":"32","author":"MJ Di\u00f3genes","year":"2012","unstructured":"Di\u00f3genes MJ, Dias RB, Rombo DM, Miranda HV, Maiolino F, Guerreiro P, N\u00e4sstr\u00f6m T, Franquelim HG, Oliveira LM, Castanho MA. Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation. J Neurosci. 2012;32(34):11750\u201362. https:\/\/doi.org\/10.1523\/jneurosci.0234-12.2012.","journal-title":"J Neurosci"},{"issue":"6","key":"709_CR347","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jnc.13060","volume":"132","author":"CR Pacheco","year":"2015","unstructured":"Pacheco CR, Morales CN, Ram\u00edrez AE, Mu\u00f1oz FJ, Gallegos SS, Caviedes PA, Aguayo LG, Opazo CM. Extracellular \u03b1-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane. J Neurochem. 2015;132(6):731\u201341. https:\/\/doi.org\/10.1111\/jnc.13060.","journal-title":"J Neurochem"},{"key":"709_CR348","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nbd.2017.03.007","volume":"109","author":"G Bieri","year":"2018","unstructured":"Bieri G, Gitler AD, Brahic M. Internalization, axonal transport and release of fibrillar forms of alpha-synuclein. Neurobiol Dis. 2018;109:219\u201325. https:\/\/doi.org\/10.1016\/j.nbd.2017.03.007.","journal-title":"Neurobiol Dis"},{"issue":"28","key":"709_CR349","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"1999","unstructured":"Wood SJ, Wypych J, Steavenson S, Louis J-C, Citron M, Biere AL. \u03b1-Synuclein fibrillogenesis is nucleation-dependent Implications for the pathogenesis of Parkinson\u2019s disease. J Biol Chem. 1999;274(28):19509\u201312. https:\/\/doi.org\/10.1074\/jbc.274.28.19509.","journal-title":"J Biol Chem"},{"issue":"9","key":"709_CR350","doi-asserted-by":"publisher","first-page":"E1206","DOI":"10.1073\/pnas.1524128113","volume":"113","author":"M Iljina","year":"2016","unstructured":"Iljina M, Garcia GA, Horrocks MH, Tosatto L, Choi ML, Ganzinger KA, Abramov AY, Gandhi S, Wood NW, Cremades N. Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading. Proc Natl Acad Sci. 2016;113(9):E1206\u201315. https:\/\/doi.org\/10.1073\/pnas.1524128113.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"709_CR351","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","volume":"920","author":"K Conway","year":"2000","unstructured":"Conway K, Lee SJ, Rochet JC, Ding T, Harper J, Williamson R, Lansbury P Jr. Accelerated oligomerization by Parkinson\u2019s disease linked \u03b1-synuclein mutants. Ann N Y Acad Sci. 2000;920(1):42\u20135. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06903.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"709_CR352","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/s0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT Jr. \u03b1-Synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol. 2002;322(5):1089\u2013102. https:\/\/doi.org\/10.1016\/s0022-2836(02)00735-0.","journal-title":"J Mol Biol"},{"issue":"6","key":"709_CR353","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"102","author":"W Li","year":"2005","unstructured":"Li W, West N, Colla E, Pletnikova O, Troncoso JC, Marsh L, Dawson TM, J\u00e4k\u00e4l\u00e4 P, Hartmann T, Price DL. Aggregation promoting C-terminal truncation of \u03b1-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc Natl Acad Sci. 2005;102(6):2162\u20137. https:\/\/doi.org\/10.1073\/pnas.0406976102.","journal-title":"Proc Natl Acad Sci"},{"issue":"1\u20133","key":"709_CR354","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s0014-5793(02)02638-8","volume":"517","author":"VN Uversky","year":"2002","unstructured":"Uversky VN, Yamin G, Souillac PO, Goers J, Glaser CB, Fink AL. Methionine oxidation inhibits fibrillation of human \u03b1-synuclein in vitro. FEBS Lett. 2002;517(1\u20133):239\u201344. https:\/\/doi.org\/10.1016\/s0014-5793(02)02638-8.","journal-title":"FEBS Lett"},{"issue":"1\u20133","key":"709_CR355","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0014-5793(03)00367-3","volume":"542","author":"G Yamin","year":"2003","unstructured":"Yamin G, Uversky VN, Fink AL. Nitration inhibits fibrillation of human \u03b1-synuclein in vitro by formation of soluble oligomers. FEBS Lett. 2003;542(1\u20133):147\u201352. https:\/\/doi.org\/10.1016\/s0014-5793(03)00367-3.","journal-title":"FEBS Lett"},{"issue":"5","key":"709_CR356","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/brain\/awx056","volume":"140","author":"H Vicente Miranda","year":"2017","unstructured":"Vicente Miranda H, Szeg\u0151 \u00c9M, Oliveira LM, Breda C, Darendelioglu E, de Oliveira RM, Ferreira DG, Gomes MA, Rott R, Oliveira M. Glycation potentiates \u03b1-synuclein-associated neurodegeneration in synucleinopathies. Brain. 2017;140(5):1399\u2013419. https:\/\/doi.org\/10.1093\/brain\/awx056.","journal-title":"Brain"},{"issue":"3","key":"709_CR357","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002601","volume":"15","author":"RM de Oliveira","year":"2017","unstructured":"de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szeg\u00f6 \u00c9M, Martinho R, Munari F, L\u00e1zaro DF, Moniot S, Guerreiro P. The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol. 2017;15(3): e2000374. https:\/\/doi.org\/10.1371\/journal.pbio.1002601.","journal-title":"PLoS Biol"},{"key":"709_CR358","doi-asserted-by":"publisher","DOI":"10.1017\/S0033583516000172","author":"R Gaspar","year":"2017","unstructured":"Gaspar R, Meisl G, Buell AK, Young L, Kaminski CF, Knowles TP, Sparr E, Linse S. Secondary nucleation of monomers on fibril surface dominates \u03b1-synuclein aggregation and provides autocatalytic amyloid amplification. Q Rev Biophys. 2017. https:\/\/doi.org\/10.1017\/S0033583516000172.","journal-title":"Q Rev Biophys"},{"issue":"5","key":"709_CR359","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM. Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med. 2012;209(5):975\u201386. https:\/\/doi.org\/10.1084\/jem.20112457.","journal-title":"J Exp Med"},{"issue":"1","key":"709_CR360","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13(1):1\u201311. https:\/\/doi.org\/10.1186\/s13024-018-0257-5.","journal-title":"Mol Neurodegener"},{"key":"709_CR361","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah3374","author":"X Mao","year":"2016","unstructured":"Mao X, Ou MT, Karuppagounder SS, Kam T-I, Yin X, Xiong Y, Ge P, Umanah GE, Brahmachari S, Shin J-H. Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. 2016. https:\/\/doi.org\/10.1126\/science.aah3374.","journal-title":"Science"},{"issue":"11","key":"709_CR362","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Temido-Ferreira M, Miranda HV, Batalha VL, Coelho JE, Szeg\u00f6 \u00c9M, Marques-Morgado I, Vaz SH, Rhee JS, Schmitz M. \u03b1-Synuclein interacts with PrP C to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci. 2017;20(11):1569. https:\/\/doi.org\/10.1038\/nn.4648.","journal-title":"Nat Neurosci"},{"issue":"1","key":"709_CR363","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00401-017-1787-6","volume":"135","author":"D Erskine","year":"2018","unstructured":"Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, Morris CM. Regional levels of physiological \u03b1-synuclein are directly associated with Lewy body pathology. Acta Neuropathol. 2018;135(1):153\u20134. https:\/\/doi.org\/10.1007\/s00401-017-1787-6.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"709_CR364","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00401-018-1829-8","volume":"135","author":"E Luna","year":"2018","unstructured":"Luna E, Decker SC, Riddle DM, Caputo A, Zhang B, Cole T, Caswell C, Xie SX, Lee VM, Luk KC. Differential \u03b1-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Acta Neuropathol. 2018;135(6):855\u201375. https:\/\/doi.org\/10.1007\/s00401-018-1829-8.","journal-title":"Acta Neuropathol"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-021-00709-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T13:04:36Z","timestamp":1637327076000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-021-00709-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":364,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["709"],"URL":"https:\/\/doi.org\/10.1186\/s13578-021-00709-y","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}